<!DOCTYPE html>
<!--[if IE 7]>                  <html class="ie7 no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">     <![endif]-->
<!--[if lte IE 8]>              <html class="ie8 no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">     <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--> <html class="not-ie no-js" lang="en" dir="ltr"
  xmlns:og="http://ogp.me/ns#"
  xmlns:article="http://ogp.me/ns/article#"
  xmlns:book="http://ogp.me/ns/book#"
  xmlns:profile="http://ogp.me/ns/profile#"
  xmlns:video="http://ogp.me/ns/video#"
  xmlns:product="http://ogp.me/ns/product#">  <!--<![endif]-->
<head>
  <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="shortcut icon" href="../sites/default/files/Favicon2.png" type="image/png" />
<meta name="description" content="U.S. Department of Health and Human Services Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities Becky Briesacher, Bruce Stuart and Jalpa Doshi University of Maryland, Peter Lamy Center June 5, 2002 PDF Version: http://aspe.hhs.gov/daltcp/reports/2002/meduse.pdf (26 PDF pages)" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html" />
<link rel="shortlink" href="https://aspe.hhs.gov/node/66251" />
<meta property="og:site_name" content="ASPE" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://aspe.hhs.gov/basic-report/medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities" />
<meta property="og:title" content="Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities" />
<meta property="og:description" content="U.S. Department of Health and Human Services Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities Becky Briesacher, Bruce Stuart and Jalpa Doshi University of Maryland, Peter Lamy Center June 5, 2002 PDF Version: http://aspe.hhs.gov/daltcp/reports/2002/meduse.pdf (26 PDF pages)" />
<meta property="og:updated_time" content="2017-02-21T11:35:07-05:00" />
<meta property="article:published_time" content="2015-12-09T05:20:49-05:00" />
<meta property="article:modified_time" content="2017-02-21T11:35:07-05:00" />

  <title>Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities | ASPE</title>
	<meta http-equiv="X-UA-Compatible" content="IE=edge"><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1026.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>

	<!-- Mobile Specific Metas
	================================================== -->
	<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=1.0,user-scalable=0">

  <link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__5ln8neBOcJfyUveiD4y9fhI6kHBLOQ_YL0mMC-LS9a0__TPJIZT9UBnf_685NlFTJ5KnZVsjwFk6ACQ-nwwygmwU__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__ng49uRH5y4Hl9VF9hHW_vXOj-mcOc2u2ShJqJ1YKIGU__FoMCD14GBvZaRiqSQ_JpP1w3rDB21n7H2Ar4pRZaIh8__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__Hskudx14OJ5Hz8vqU7CUgN6SDV5rINZuEq9VuGsSeyc__EwNIl3xeFrniW2TmonovTzhSs3X5MdFps210puE7jog__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__9rZoaX9BdzjjNucvYxduxeNAVO2zgW_Rvjhb5rq5whc__lSr_y16grDSgHf4booPChnF7QXz3TQY3hafH49twE0k__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__ZgfI_ZPib5yVY0o5aKo_6TFn946Tuu_nFDa0ySTmkSc__2FTFrNw2eNh0mpHIOA34r6YRwBZMm2PjJ_JubnwLigg__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__dxabpJ5rQgDSixKgLJZjWc1beC6mpROKwVrmWxI5eno__rqhz_hGsE_i59O7-W991o71_Jxw1QOtGMxn4nsOLHY8__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />
<link type="text/css" rel="stylesheet" href="../sites/default/files/advagg_css/css__ZbRCq2NqWgK-HXAQI3So0N1n0nr4HonsJS3eQuuxukw__7Olkk8Locn8Dj0eR0Ww3rbV9lks9sxipcboMXB18RRs__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.css" media="all" />

	<!-- Head Libs -->
	<script src="../sites/all/themes/stability/stability_aspe/vendor/modernizr.js"></script>

	<!--[if lt IE 9]>
		<script src="http://html5shim.googlecode.com/svn/trunk/html5.js"></script>
		<script src="/sites/all/themes/stability/vendor/respond.min.js"></script>
	<![endif]-->

	<!-- Favicons
	================================================== -->
	<link rel="apple-touch-icon" href="../sites/all/themes/stability/images/apple-touch-icon.png">
	<link rel="apple-touch-icon" sizes="72x72" href="../sites/all/themes/stability/images/apple-touch-icon-72x72.png">
	<link rel="apple-touch-icon" sizes="114x114" href="../sites/all/themes/stability/images/apple-touch-icon-114x114.png">
	<link rel="apple-touch-icon" sizes="144x144" href="../sites/all/themes/stability/images/apple-touch-icon-144x144.png">

</head>
<body class="html not-front not-logged-in no-sidebars page-node page-node- page-node-66251 node-type-basic-report">
<!-- Google Tag Manager -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-JLFR"
                  height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
  })(window,document,'script','dataLayer','GTM-JLFR');</script>
<!-- End Google Tag Manager -->
  <div id="skip-nav" class="accessibility_menu">
    <strong>Shortcut Navigation:</strong>
    <ul>
      <li><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#content" accesskey="c" title="Skip to page content (ctrl/alt + c)">Page Content</a></li>
      <li><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#nav" accesskey="m" title="Skip to main navigation menu (ctrl/alt + m)">Site Navigation</a></li>

      <li><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#Footer" accesskey="f" title="Skip to footer (ctrl/alt + f)">Footer</a></li>
    </ul>
  </div>


<div class="site-wrapper">

  <header class="header header-menu-fullw header-top-clean">
    <div id="brand-bar">
        <div class="container">
                    <img alt='bird' src="../sites/all/themes/stability/stability_aspe/images/bird.png"> <a target="blank" tabindex="4" href="http://www.hhs.gov/">U.S. Department of Health & Human Services</a>
        </div>

    </div>
    <div class="header-main">
        <div class="container clearfix">
            <div class="social-links-wrapper">
                <ul class="social-links social-links__light">
                                                          <li><a href="http://twitter.com/hhs_aspe"><img alt="twitter" src="../sites/all/themes/stability/stability_aspe/images/tw.png"/></a></li>
                                    <!--                  --><!--                    <li><a href="http://--><!--"><img alt="linkedin" src="--><!--/images/linkedin.png"/></a></li>-->
<!--                  -->
                                                                      </ul>
            </div>
            <!-- Logo -->
            <div class="logo">
                                <div class="site_name_wrapper">
                                     <span class="h1">
                                      <a href="../images/exit_disclaimer.jpg.html">ASPE</a>
                                       </span>
                                  <p class="tagline"><p>Office of The Assistant Secretary</p><p> for Planning and Evaluation</p></p>
                    </div>
            </div>
            <!-- Logo / End -->
            <div class="header_right_wrapper">
                <div class="search-form">
                    <form action="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html" method="post" id="search-block-form" accept-charset="UTF-8"><div><div class="container-inline">
  <div class = "input-group"><div class="form-type-textfield form-item-search-block-form form-item form-group">
  <label class="element-invisible" for="edit-search-block-form--2">Search </label>
 <input title="Enter the terms you wish to search for." placeholder="Search Site..." class="form-control form-control form-text" type="text" id="edit-search-block-form--2" name="search_block_form" value="" size="15" maxlength="128" />
</div>
<div class="form-actions form-wrapper" id="edit-actions--2"><input class="btn btn-primary btn-icon form-submit" type="image" id="edit-submit" name="submit" value="Search" src="../sites/all/themes/stability/stability_aspe/images/search-white2.png" alt="Search" title="Search" /></div></div><input type="hidden" name="form_build_id" value="form-kSMFw6HR884U587B7EbBqz2ZsSL7_t66MCLeKtLOHwA" />
<input type="hidden" name="form_id" value="search_block_form" />
</div>
</div></form>                </div>
                <button type="button" class="navbar-toggle" value="Menu">
                    <i class="fa fa-bars"></i>Menu
                </button>
            </div>

        </div>
    </div>

    <!-- Navigation -->
    <nav id="nav" class="nav-main">
        <div class="container">
          <ul data-breakpoint="767" class="flexnav">
                <li class="first expanded"><a href="../basic-search/about.html" title="">About</a><ul><li class="first leaf"><a href="../node/41366.html" title="">Mission</a></li>
<li class="leaf"><a href="../key-staff.html" title="">Leadership</a></li>
<li class="leaf"><a href="https://www.usajobs.gov/" title="">Careers</a></li>
<li class="expanded"><a href="../node/83081.html" title="linkTo">Coordination</a><ul><li class="first leaf"><a href="../node/94561.html" title="">Evaluation &amp; Evidence</a></li>
<li class="leaf"><a href="../node/83126.html">National Alzheimer&#039;s Project Act</a></li>
<li class="leaf"><a href="../hhs-data-council.html">HHS Data Council</a></li>
<li class="last leaf"><a href="../node/83076.html" title="National Council on Vital and Health Statistics">National Council on Vital and Health Statistics</a></li>
</ul></li>
<li class="expanded"><a href="../basic-search/divisions.html" title="">Offices</a><ul><li class="first leaf"><a href="../daltcp/home.htm">Disability, Aging, and Long-Term Care Policy</a></li>
<li class="leaf"><a href="../node/57001.html">Health Policy</a></li>
<li class="leaf"><a href="../hsp/index.shtml.html">Human Services Policy</a></li>
<li class="last leaf"><a href="../node/57011.html">Science and Data Policy</a></li>
</ul></li>
<li class="leaf"><a href="../node/83096.html" title="Strategic Planning">Strategic Planning</a></li>
<li class="last leaf"><a href="../node/83911.html" title="">Contact ASPE</a></li>
</ul></li>
<li class="expanded"><a href="../basic-search/topics.html" title="">Topics</a><ul><li class="first leaf"><a href="../health/reports/2012/ACA-Research/index.cfm.html">Affordable Care Act Research</a></li>
<li class="leaf"><a href="../node/101296.html">Alzheimer&#039;s / Dementia</a></li>
<li class="leaf"><a href="../node/105551.html">Early Childhood</a></li>
<li class="leaf"><a href="../node/103281.html">Incarceration &amp; Reentry</a></li>
<li class="leaf"><a href="../node/83056.html" title="Opioids">Opioids</a></li>
<li class="leaf"><a href="../node/83296.html">Patient-Centered Outcomes Research Trust Fund (PCORTF)</a></li>
<li class="expanded"><a href="../basic-search/poverty.html" title="">Poverty</a><ul><li class="first leaf"><a href="../node/107166.html">Poverty Guidelines</a></li>
<li class="last leaf"><a href="../node/107171.html">Poverty Analysis</a></li>
</ul></li>
<li class="leaf"><a href="../node/164501.html">Teen Pregnancy Prevention</a></li>
<li class="leaf"><a href="../node/100556.html">Homelessness</a></li>
<li class="last leaf"><a href="../node/117441.html">MACRA</a></li>
</ul></li>
<li class="leaf"><a href="../reports.html" title="">Publications</a></li>
<li class="last expanded"><a href="../basic-search/datasets.html" title="">Data and Tools</a><ul><li class="first last leaf"><a href="../pic/index.cfm.html" title="">Evaluation Database</a></li>
</ul></li>
            </ul>
        </div>
    </nav>
    <!-- Navigation / End -->
</header>  <div class="main" role="main">
    <!--PAGEWATCH CODE="USHHS_458"-->
    <section class="page-heading">
  <div class="container">
    <div class="row">

        <div class="col-md-6">
                <h1>

          Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities        </h1>
                                 <p class="author">
                                                 <span class="date-display-single" property="dc:date" datatype="xsd:dateTime" content="2002-06-05T00:00:00-04:00">06/05/2002</span>
                           </p>


                  </div>


        <div class="col-md-6">
           <ul class="breadcrumb"><li class="first"><a href="../images/exit_disclaimer.jpg.html" title="Home">Home</a></li>
<li class="last">Medication Use by Medicare Ben...</li>
</ul>        </div>


    </div>
  </div>
</section>

      <div  class="nd-region nd-region-filter">




      <div  id="Filter" class="row">


















      </div>



      </div>



      <div  class="nd-region nd-region-similar-content">




      <div  id="Similar-Content" class="row">




                                    <div  id="top" class="">

                              <div id="block-views-2100ccfdd214bdbcf634d7e4832c265b" class="widget block block-views solr-similar-content" >

        <div class="title-accent">
			<h3 class = "widget-title" ><span>Similar</span> content</h3>
		</div>

  <div class="view view-similar-content-solr view-id-similar_content_solr view-display-id-block_solr_similar_content view-dom-id-8489adeb812a760cdf77095c57b0bc0c">





    <span class="field-content"><a href="../pdf-report/medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html">Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities</a></span>
    <span class="field-content"><a href="national-estimates-prescription-drug-utilization-and-expenditures-long-term-care-facilities.html">National Estimates of Prescription Drug Utilization and Expenditures in Long-Term Care Facilities</a></span>
    <span class="field-content"><a href="https://aspe.hhs.gov/basic-report/national-comparison-prescription-drug-expenditures-medicare-beneficiaries-living-community-and-long-term-care-facility-settings">A National Comparison of Prescription Drug Expenditures by Medicare Beneficiaries Living in the Community and Long-Term Care Facility Settings</a></span>
    <span class="field-content"><a href="medication-use-long-term-care-facilities-and-community-settings-medicare-beneficiaries-cardiovascular-disease.html">Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease</a></span>
    <span class="field-content"><a href="../execsum/prescription-drug-spending-medicare-beneficiaries-institutional-and-residential-settings-1998-2001.html">Prescription Drug Spending by Medicare Beneficiaries in Institutional and Residential Settings, 1998-2001</a></span>





</div>
  </div> <!-- /.block -->

                          </div>














      </div>



      </div>



      <div  class="nd-region">



          <div class = "container">

      <div  class="row" id="Content">








                                    <div  class="col-md-12 " id="content">

                              <div id="block-aspe-aspe-addthis" class="widget block block-aspe" >


  <div class="clearfix">
  <ul class="addthis_sharing_toolbox node-share__links" data-url="https://aspe.hhs.gov/basic-report/medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities" data-title="Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities">
    <li><a class="addthis_button_print"><img src="../sites/all/themes/stability/stability_aspe/images/print-white.png" alt="print" /></a></li>
    <li><a class="addthis_button_email"><img src="../sites/all/themes/stability/stability_aspe/images/mail-white.png" alt="email" /></a></li>
    <li><a class="addthis_button_twitter"><img src="../sites/all/themes/stability/stability_aspe/images/tw.png" alt="twitter" /></a></li>
<!--    <li><a class="addthis_button_facebook">--><!--</a></li>-->
    <li><a class="addthis_button_compact"><img src="../sites/all/themes/stability/stability_aspe/images/plus-white.png" alt="compact" /></a></li>
  </ul>
</div>

  </div> <!-- /.block -->




  <div class="content clearfix node-basic-report">
    <p><font><b><font face="Calisto MT">U.S. Department of Health and Human Services</font></b></font></p>
<h1>Medication Use by Medicare Beneficiaries Living in  		Nursing Homes and Assisted Living Facilities</h1>
<h3>Becky Briesacher, Bruce Stuart and Jalpa Doshi</h3>
<h3>University of Maryland, Peter Lamy Center</h3>
<h3>June 5, 2002</h3>
<p>PDF Version:  		<a href="https://s3-sa-east-1.amazonaws.com/ea-web-scrapes/aspe.hhs.gov/system/files/pdf/73256/meduse.pdf">http://aspe.hhs.gov/daltcp/reports/2002/meduse.pdf</a>  		(26 PDF pages)</p>
<hr /><blockquote>
<p><i>This report was prepared under contract #HHS-100-01-0023 between  		  the U.S. Department of Health and Human Services (HHS), Office of Disability,  		  Aging and Long-Term Care Policy (DALTCP) and the University of Maryland. For  		  additional information about this subject, you can visit the DALTCP home page  		  at <a href="../_/office_specific/daltcp.cfm.html">http://aspe.hhs.gov/_/office_specific/daltcp.cfm</a> or contact the office at  		  HHS/ASPE/DALTCP, Room 424E, H.H. Humphrey Building, 200 Independence Avenue,  		  S.W., Washington, D.C. 20201. The e-mail address is: <a href="mailto:webmaster.DALTCP@hhs.gov">webmaster.DALTCP@hhs.gov</a>.  		  The Project Officer was Andreas Frank.</i></p>
<p><i> The opinions and views expressed in this report are those of the  		  authors. They do not necessarily reflect the views of the Department of Health  		  and Human Services, the contractor or any other funding organization.</i></p>
</blockquote>
<hr /><h2>TABLE OF CONTENTS</h2>
<dl><dt><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#abs">ABSTRACT</a></dt>
</dl><dl><dt><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#intro">INTRODUCTION</a></dt>
</dl><dl><dt><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#method">METHODS</a></dt>
</dl><dl><dt><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#study">STUDY FINDINGS</a></dt>
</dl><dl><dt><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#conclude">CONCLUSIONS</a></dt>
</dl><dl><dt><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#ref">REFERENCES</a></dt>
</dl><dl><dt><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#appendix">APPENDIX</a></dt>
</dl><dl><dt>LIST OF TABLES</dt>
<dd><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table1">TABLE 1</a>: Institutional Medicare Beneficiaries  		  by Type of Facility Stay and Resident Characteristics, 1998 </dd>
<dd><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table2">TABLE 2</a>: Institutional Medicare Beneficiaries  		  by Type of Facility Stay and Resident Health Status, 1998 </dd>
<dd><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table3">TABLE 3</a>: Mean Number of Drug Mentions per Month  		  for Institutionalized Medicare Beneficiaries by Type of Facility Stay, 1998  		  </dd>
<dd><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table4">TABLE 4</a>: Frequency Distribution of Mean Number  		  of Drug Mentions per Month for Institutionalized Medicare Beneficiaries by Type  		  of Facility Stay, 1998 </dd>
<dd><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table5">TABLE 5</a>: Mean Number of Drug Mentions per Month  		  for Institutionalized Medicare Beneficiaries by Type of Facility Stay and  		  Health Insurance Coverage, 1998 </dd>
<dd><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table6">TABLE 6</a>: Prevalence and Duration of Drugs Used  		  by Medicare Beneficiaries in Nursing Facilities and Assisted Living and Related  		  Facilities by Descending Order of Prevalence of Drug Class in Nursing  		  Facilities, 1998 </dd>
<dd><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#tableA1">TABLE A1</a>: Distribution of Beneficiaries in  		  the 1998 MCBS Facility Sample with Institutional Drug Administrations by Type  		  of Facility Stay </dd>
<dd><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#tableA2">TABLE A2</a>: Characteristics of Facilities from  		  which Residents Sampled</dd>
</dl><h2>ABSTRACT</h2>
<h3>Objectives</h3>
<p>This report compares the medication use of Medicare beneficiaries living  		in nursing homes and assisted living facilities. Descriptions of medication use  		include mean number of drug mentions per month of stay (scheduled and PRN  		drugs), and prevalence and duration of therapy by major drug classes.  		Characteristics of institutionalized beneficiaries include demographics,  		income, regional residence, Medicare supplemental coverage, any community  		residence or skilled-nursing stays, death, health status, activities of daily  		living scores, and major medical conditions.</p>
<h3>Methods</h3>
<p> Data are from the 1998 Medicare Current Beneficiary Survey (MCBS)  		facility and institutional drug files. The MCBS facility file captures a  		comprehensive picture of Medicare beneficiaries residing in institutions. The  		institutional drug use file contains chart abstracts of medications prescribed  		or administered to residents while institutionalized. The study sample  		comprised 1,182 institutionalized beneficiaries with medication records. </p>
<h3>Results</h3>
<p> In 1998, approximately 1.9 million Medicare beneficiaries lived in a  		nursing facility (NF) during the year and about 640,000 resided in assisted  		living and related facilities (ALF). Virtually all beneficiaries in facilities  		used some medications, and mean monthly use is eight prescriptions. Regularly  		scheduled medications comprised most drug regimens although drugs administered  		on an "as needed" basis were common (73% of NF residents vs. 63% of ALF  		residents). Beneficiaries whose institutional stay was paid for at least  		partially by Medicare have higher than average monthly prescription use (nine  		in NF, ten in ALF). Having Medicare supplemental coverage (especially private)  		is associated with mean monthly drug use in the assisted living facilities but  		not in nursing homes. The most prevalent drugs taken by residents in either  		setting were analgesics and antipyretics (82% NF vs. 71% ALF). Use of  		gastrointestinal drugs was higher for residents with nursing home stays than  		those with assisted living stays (79% vs. 65%). This difference stemmed mainly  		from the frequent use of cathartics and laxatives in nursing homes (64% vs.  		47%). Anti-infective use was also higher in nursing homes than in assisted  		living facilities (64% vs. 51%), in particular, use of antibiotics (54% vs.  		40%). Nearly 70% of the residents in both settings received central nervous  		system agents, usually used to treat depression, anxiety and psychoses. Between  		38% and 41% of institutionalized beneficiaries received antidepressant  		therapies and about 23% took antipsychotics. Use of cardiovascular agents such  		as ace-inhibitors, cardiac stimulants, and calcium channel blockers were also  		similar in both environments. More nursing home residents than assisted living  		residents took anticoagulants or thrombolytics (16% vs. 9%). With the exception  		of anti-infectives, most of the drugs listed here were taken for half to three  		quarters of the period during which the beneficiaries were in residence. </p>
<h3>Conclusions</h3>
<p> These national estimates of institutional drug use serve as the first  		benchmarks of prescribing patterns in nursing homes and assisted living  		facilities. Medicare beneficiaries in these setting typically receive many  		different kinds of medications each month, and at least a third have monthly  		drug regimens that include more than nine different medications. Future  		research should assess the appropriateness of these drug therapies.  		Associations detected between having Medicare supplemental coverage and monthly  		prescription use in assisted living facilities potentially raise questions  		about sufficient drug coverage that deserve further investigation.</p>
<h2>INTRODUCTION</h2>
<p> This report is the first to provide national estimates of medication  		utilization for Medicare beneficiaries living in nursing homes and assisted  		living and related facilities. We cover basic measures of drug use including  		mean number of drug mentions per month of institutional stay (scheduled and PRN  		drugs), and prevalence and duration of drug therapy by major drug classes.  		Characteristics of institutionalized beneficiaries include demographics,  		income, regional residence, Medicare supplemental coverage, any community  		residence or skilled-nursing facility stays, death, health status, activities  		of daily living scores, and major medical conditions. This paper also presents  		the first comparison of institutional medication use by residence in nursing  		facilities or assisted living and related facilities. </p>
<p> Previously, no nationally-representative estimates existed on the drug  		use of institutionalized Medicare beneficiaries because no data were available  		for that purpose. Most studies of prescribing patterns in institutional  		settings use small and geographically isolated samples, and thus the findings  		are not generalizable to the country at large. As a result, we have never known  		the most common or most persistent medications administered in long-term care  		facilities or assisted living facilities. Our knowledge of medication use in  		these settings has been pieced together through a collection of fragmented  		efforts. Our understanding of drugs administered in the nursing home  		environment comes from surveys of consultant pharmacists and a study using  		Minimum Data Set (MDS) records from the handful of states that systematically  		collect drug data. (Tobias 1997, Tobias 2001, Hume 1998) Overall drug use  		patterns in assisted living facilities are drawn from a single study using the  		database of one long-term care pharmacy provider. (Armstrong 2001) In all the  		above cases, these estimates came from data captured retrospectively and for  		only a short period of time (e.g., medication use in the last seven days or in  		the last one month). These studies cannot provide information on the duration  		of use and the reported prevalence rates may be underestimated. Only one  		analysis has attempted to compare medication use in the two institutional  		settings, although large differences in the data collection methods make the  		evaluation difficult to interpret. (Armstrong 2001) </p>
<p> Appreciating why institutional medication use is not simply a more  		intense version of community medication use requires an understanding of how  		drugs are dispensed and paid for in these environments. Private drug coverage  		is far less common in nursing homes and assisted living facilities, and the  		options for getting the medications filled there are often restricted. Nursing  		home residents are technically free to obtain their prescriptions at any  		pharmacy as long as it meets the facility's requirements for special packaging  		and extra services. In practice, few pharmacies meet these standards so nearly  		all residents use the long-term care pharmacy provider chosen by the facility.  		Assisted living facilities generally impose fewer rules on acceptable  		pharmacies so residents are freer to use outside pharmacies. Sole source  		pharmacy providers generally deliver the medications to the facility and handle  		the recordkeeping and billing for medications used. In most cases, the  		resident's facility negotiates the contract terms with the long-term care  		pharmacy that are binding to its residents, but the facility has little direct  		involvement with managing drug costs. </p>
<p> The main payers for medicines used in nursing homes are public  		programs. Most beneficiaries enter long-term care facilities following a  		serious hospitalization. This transfer of acute care to the nursing home  		initiates a Medicare Part A benefit that includes temporary drug coverage.  		Medicare covers drug costs as part of a prospective per diem rate for  		beneficiaries admitted after a hospital stay lasting at least three days. This  		arrangement can last up to 100 days although most Medicare-covered stays are  		much shorter since only 60 consecutive days are allowable under this benefit.  		During this special period of Medicare coverage, beneficiaries pay nothing for  		their medicines for 20 days and then about $100 a day for all nursing home care  		including drugs. Nursing homes face potential risk for high drug costs during  		Medicare-covered days so some facilities negotiate daily medication rates with  		long-term care pharmacy providers. In turn, pharmacies limit their financial  		exposure by arranging risk-sharing bands around the per diem rate or  		fee-for-service exceptions for expensive medications. These contracts are  		generally proprietary and thus the details of these agreements are not well  		known.</p>
<p> Although Medicare Part A constitutes an important source of short-term  		drug coverage, Medicaid actually picks up the tab for most medications  		dispensed in nursing homes. The majority of residents enter with Medicaid  		eligibility or acquire it shortly after admittance since the costs of  		institutional care rapidly exhaust the personal resources of average  		beneficiaries. With rare exception, Medicaid programs pay for medications on a  		fee-for-service basis. Long-term care pharmacy providers transmit prescription  		claims directly to state Medicaid programs for reimbursement (exceptions  		include California and New York where medications costs are bundled with other  		institutional services.) For the other states, Medicaid reimburses long-term  		care pharmacies at the same medication prices as those given to retail  		pharmacies. There are, however, some state-to-state variations in what are  		allowable costs that are particularly relevant to institutional settings. Some  		Medicaid programs cover the costs of commonly prescribed over-the-counter drugs  		in nursing homes (e.g., vitamins). Some states also permit multiple dispensing  		fees for each prescription filled, while others impose a flat dispensing fee  		per resident per month. </p>
<p> The next largest payer is third-party prescription plans. In general,  		the drug coverage beneficiaries had while living in the community transfers  		with them into the nursing home. When nursing homes contract with a long-term  		care pharmacy provider, the selected pharmacy agrees to honor the third-party  		prescription coverage of all residents and to bill those plans directly. Many  		private drug plans do not, however, cover the costs of additional pharmacy  		services required by the facility (such as repacking the medications into  		blister packs and delivering them to the facility). Some long-term care  		pharmacy providers recoup these expenses by billing the resident for any  		uncovered services. </p>
<p> The last source of drug coverage in institutions is an assortment of  		public plans comprising mostly state pharmaceutical assistance programs. The  		benefits of these programs vary considerably and eligibility depends on a  		variety of income and assets tests. But, for the near-poor residents of three  		states (Pennsylvania, New Jersey and New York) these public plans offer  		substantial drug coverage to institutionalized patients. In general, these  		programs operate similarly to Medicaid, and medications are reimbursed on a  		fee-for-service basis.</p>
<p> For residents with no source of drug coverage, medications are paid for  		out-of-pocket. In these cases, the long-term care pharmacy provider bills the  		residents each month, and payments are made either by the resident or family  		members. </p>
<p> Drug coverage in assisted living and related facilities more closely  		resembles that found in the community although there are some peculiarities.  		Residents in this setting usually pay for their medications through private  		third-party plans or out-of-pocket. Public coverage is less common compared to  		nursing homes as most states do not allow Medicaid reimbursement for services  		rendered in assisted living facilities. Many assisted living facilities  		contract with long-term care pharmacy providers under similar contractual terms  		as nursing homes. Some assisted living facilities require that their residents  		fill all medications through the selected pharmacy provider, although most  		allow residents to use retail pharmacies, either directly or with the help of  		family members or friends. In cases of sole source long-term care pharmacies,  		residents of assisted living facilities pay higher medications prices than if  		purchasing them from retail pharmacies.</p>
<h2>METHODS</h2>
<p>This paper uses a merged dataset of the 1998 Medicare Beneficiary Survey  		(MCBS) Cost and Use facility file and the institutional drug administration  		(IDA) file. The facility file captures a comprehensive picture of Medicare  		beneficiaries residing in institutions. Institutional care is broadly defined  		and includes licensed nursing homes and other long-term care facilities such as  		retirement homes, domiciliary or personal care facilities, and assisted living  		facilities. Domains in the MCBS facility file include beneficiary demographics,  		income, regional residence, Medicare supplemental coverage, any community  		residence or skilled-nursing stays, health status, activities of daily living  		scores, major medical conditions and death. Type of institutional stay comes  		from the facility-reported descriptions. We defined assisted living and related  		facility stay for those described as: assisted living facility, domiciliary  		care home, personal care home, life care facility, continuing care retirement  		community, or retirement home.</p>
<p> The institutional drug use file contains monthly chart abstracts of  		medications prescribed to residents while institutionalized. Surveyors record  		all medicines listed on the resident's medication chart, including prescribed  		and over-the-counter medicines, and the number of administrations. This  		includes prescriptions given at regular intervals or those given as PRN or  		standing orders. In our analyses, we included only drugs administered at least  		once during the month. We also excluded drug mentions that were classified as  		durable medical equipment, medical supplies/devices, and pharmaceutical  		adjuvants.</p>
<p> The study sample comprised 1,182 institutional beneficiaries with  		medication records. The MCBS facility sample consists of individuals who reside  		in long-term care settings at the time of their survey interview (MCBS sample  		persons are drawn from Medicare enrollment records without regard to their  		institutional status). The facility sample is representative of the Medicare  		population in long-term care facilities. Each sample person has information on  		all living situations during the year. We track residents as they moved from  		the community to the facility, from facility to facility, or from facility to  		death. Monthly drug use was mapped to these residence histories to create  		estimates of mean drug use per person month while in each facility type. </p>
<p>All estimates are weighted. Estimates failing reliability thresholds of  		cell size less than 20 sample persons are noted in the tables. (See the  		<a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#appendix">appendix</a> for additional details on the study  		methods.)</p>
<h2>STUDY FINDINGS</h2>
<p><i>Socio-economic characteristics</i>: <a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table1">Table 1</a>  		presents the characteristics of institutionalized Medicare beneficiaries by  		type of facility stay. In 1998, approximately 1.9 million Medicare  		beneficiaries lived in a nursing facility during the year and about 640,000  		resided in assisted living facilities. Both populations show relatively similar  		socio-economic traits, although assisted living residents are slightly younger  		than nursing homes, more often white and have somewhat higher incomes. More  		notable differences are apparent with supplemental Medicare coverage. Far more  		beneficiaries in assisted living facilities than in nursing homes have some  		form of private health insurance during the year (50% vs. 36%). Nursing home  		residents rely more often on Medicaid coverage than assisted living residents  		(65% vs. 39%). Both populations show substantial movement between living in the  		community and facility: over one in three residents of assisted living  		facilities lived in the community at some time during the year compared to one  		in four nursing home residents. About 25% of the nursing home population died  		during the year compared to 15% of the assisted living population.</p>
<p><i>Health status</i>: For every measure of health status evaluated,  		nursing home residents show greater frailty than assisted living residents:  		they have worse health status, higher prevalence of medical conditions and more  		physical impairments (see <a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table2">Table 2</a>). This finding was  		expected, however the only slightly better health of the assisted living  		population was surprising. Almost 30% of assisted living residents have  		dementia/Alzheimer's disease or heart disease (compared to about 40% of nursing  		home residents.) Both populations share a similar prevalence of mental  		disorders (about 40%). Nearly 60% of assisted living residents have  		difficulties performing three or more activities of daily living (compared to  		72% of nursing home residents) and almost half of this population suffers from  		some urinary incontinence (compared to 61% of nursing home residents). </p>
<p><i>Average drug use</i>: Average monthly drug use looks similar in the  		two institutionalized populations. <a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table3">Table 3</a> shows that  		virtually all beneficiaries in facilities used some medications, and mean  		monthly use is eight prescriptions. Regularly scheduled medications comprise  		most of the drug regimen although drugs administered on an "as needed" basis  		are common for residents of both nursing homes and assisted living facilities  		(73% vs. 63%).</p>
<p><a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table4"> Table 4</a> presents a more detailed picture of  		average monthly drug use in institutions. About 9% of nursing home residents  		and 14% of assisted living residents take simple medication regimens consisting  		of one or two different drug therapies in the course of a month. Most  		residents, though, take about three to eight different medicines every month  		(62% in nursing homes vs. 60% in assisted living facilities). Highly complex  		drug regimens of nine or more medicines in a month are taken by about 40% of  		nursing home residents and 34% of assisted living residents. The next two  		distributions of monthly medication use show that about half of all  		institutionalized beneficiaries take PRNs frequently enough to exceed an  		average of one or more per month.</p>
<p> The relationship between average drug use and having supplemental  		health insurance varies by setting. Mean monthly medication use appears stable  		among nursing home residents regardless of whether or not they have Medicaid,  		private insurance or other public coverage (See <a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table5">Table 5</a>).  		That is not the case for assisted living residents: those without any health  		coverage besides Medicare use six prescriptions per month on average, while  		those with private health plans (either with or without Medicaid coverage) tend  		to use eight to nine prescriptions per month. Beneficiaries whose institutional  		stay was paid for at least partially by Medicare also have higher than average  		monthly prescription use, an association evident in both settings.</p>
<p><i>Use of therapeutic drug classes</i>: <a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#table6">Table 6</a>  		presents the types of medications most commonly used in nursing homes and  		assisted living facilities. The columns capture the prevalence of use and the  		duration of use. Overall, drug use is similar across settings although there  		are some notable exceptions. The most prevalent drugs taken by residents in  		either environment are analgesics and antipyretics. This indicates that pain  		management is the number one use of drugs in nursing homes or assisted living  		facilities. Nursing home residents tend to use more non-salicylate analgesics  		such as acetaminophen (61% vs. 47%) and narcotic analgesics (30% vs. 25%) than  		assisted living facility residents. Use of gastrointestinal drugs is also  		higher for residents with nursing home stays than those with assisted living  		stays (79% vs. 65%). This difference stems mainly from the frequent use of  		cathartics and laxatives in nursing homes (64% vs. 47%). Anti-infective use is  		also higher in nursing homes than in assisted living facilities (64% vs. 51%),  		in particular, antibiotics (54% vs. 40%). This reflects the high susceptibility  		of frail nursing home residents to infections. Nearly 70% of the residents in  		both settings received central nervous system agents, usually used to treat  		depression, anxiety and psychoses. Between 38% and 41% of the residents in  		either setting receive antidepressant therapies and about 23% take  		antipsychotics. Use of cardiovascular agents such as ace-inhibitors, cardiac  		stimulants, and calcium channel blockers are also similar in both environments.  		More nursing home residents than assisted living residents do, however, take  		anticoagulants or thrombolytics (16% vs. 9%). With the exception of  		anti-infectives, most of the drugs listed here are taken for half to three  		quarters of the period the beneficiaries are in residence. </p>
<h2>CONCLUSIONS</h2>
<p> These estimates of institutional drug use serve as the first  		national-level benchmarks of prescribing patterns in nursing homes and assisted  		living facilities. Medicare beneficiaries in these setting typically receive  		many different kinds of medications each month, and at least a third have drug  		regimens exceed the Minimum Data Set Quality Indicator that nursing home  		residents receive no more than nine different medications. Future research  		should assess the appropriateness of these drug therapies. Associations  		detected between having Medicare supplemental coverage and monthly prescription  		use in assisted living facilities raise questions about drug coverage that  		deserve further investigation.</p>
<h2>REFERENCES</h2>
<p>Armstrong EP, Rhoads M, Meiling F. Medication usage patterns in assisted  		living facilities. Consult Pharm 1997; 12:1401-8.</p>
<p>Tobias DE, Pulliam CC. General and psychotherapeutic medication use in  		878 nursing facilities: a 1997 national survey. Consult Pharm 1997;  		12:1401-8.</p>
<p> Tobias DE, Sey M. General and psychotherapeutic medication use in 328  		nursing facilities: a year 2000 national survey. Consult Pharm 2001;  		16:54-64.</p>
<p>Hume AL, Lapane KL, Middleton S, et al. The SAGE database: Medication  		use in elderly nursing facility residents. Consult Pharm 1998;13:1356-64.</p>
<table title="TABLE 1. Institutional Medicare Beneficiaries by Type of Facility Stay and Resident Characteristics, 1998"><tr><td colspan="3"><font><b><a name="table1" id="table1">TABLE 1</a>. Institutional Medicare  			 Beneficiaries by Type of Facility Stay and Resident Characteristics,  			 1998</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font><b>Beneficiary  			 Characteristics</b></font></td>
<td colspan="2" scope="col"><font><b>Percent  			 Beneficiaries</b></font></td>
</tr><tr><td scope="col"><font><b>  Any Nursing  Facility  			 Stay</b></font></td>
<td scope="col"><font><b>  Any Assisted Living  			 or  Related Facility Stay<sup>a</sup></b></font></td>
</tr><tr><td scope="row"><font>Total</font></td>
<td><font>1,905,487</font></td>
<td><font>638,596</font></td>
</tr><tr><td colspan="3" scope="row"><font>Age (years)</font></td>
</tr><tr><td scope="row"><font>   Under 65</font></td>
<td><font>6.9</font></td>
<td><font>14.4</font></td>
</tr><tr><td scope="row"><font>   65-74</font></td>
<td><font>10.8</font></td>
<td><font>9.1*</font></td>
</tr><tr><td scope="row"><font>   75-84</font></td>
<td><font>32.3</font></td>
<td><font>30.8</font></td>
</tr><tr><td scope="row"><font>   85+</font></td>
<td><font>50.0</font></td>
<td><font>45.8</font></td>
</tr><tr><td colspan="3" scope="row"><font>Gender</font></td>
</tr><tr><td scope="row"><font>   Female</font></td>
<td><font>70.1</font></td>
<td><font>69.9</font></td>
</tr><tr><td scope="row"><font>   Male</font></td>
<td><font>29.9</font></td>
<td><font>30.1</font></td>
</tr><tr><td colspan="3" scope="row"><font>Race</font></td>
</tr><tr><td scope="row"><font>   White</font></td>
<td><font>86.3</font></td>
<td><font>93.8</font></td>
</tr><tr><td scope="row"><font>   Non-white</font></td>
<td><font>13.7</font></td>
<td><font>5.2</font></td>
</tr><tr><td colspan="3" scope="row"><font>Income</font></td>
</tr><tr><td scope="row"><font>   &lt;$5,000</font></td>
<td><font>15.6</font></td>
<td><font>10.8</font></td>
</tr><tr><td scope="row"><font>   $5,000-$10,000</font></td>
<td><font>43.8</font></td>
<td><font>46.5</font></td>
</tr><tr><td scope="row"><font>   $10,001-$20,000  </font></td>
<td><font>26.8</font></td>
<td><font>24.2</font></td>
</tr><tr><td scope="row"><font>   $20,001-$30,000</font></td>
<td><font>9.6</font></td>
<td><font>10.6</font></td>
</tr><tr><td scope="row"><font>   &gt;$30,000</font></td>
<td><font>4.2</font></td>
<td><font>8.0</font></td>
</tr><tr><td colspan="3" scope="row"><font>Urban/Rural Residence</font></td>
</tr><tr><td scope="row"><font>   Urban</font></td>
<td><font>71.4</font></td>
<td><font>74.8</font></td>
</tr><tr><td scope="row"><font>   Rural</font></td>
<td><font>28.6</font></td>
<td><font>25.2</font></td>
</tr><tr><td colspan="3" scope="row"><font>Census Region</font></td>
</tr><tr><td scope="row"><font>   Midwest</font></td>
<td><font>33.7</font></td>
<td><font>29.5</font></td>
</tr><tr><td scope="row"><font>   South</font></td>
<td><font>32.0</font></td>
<td><font>32.4</font></td>
</tr><tr><td scope="row"><font>   Northeast</font></td>
<td><font>19.9</font></td>
<td><font>20.6</font></td>
</tr><tr><td scope="row"><font>   West</font></td>
<td><font>14.0</font></td>
<td><font>15.6</font></td>
</tr><tr><td colspan="3" scope="row"><font>Source of Medicare Supplemental Coverage</font></td>
</tr><tr><td scope="row"><font>   Private only<sup>b</sup></font></td>
<td><font>19.5</font></td>
<td><font>39.3</font></td>
</tr><tr><td scope="row"><font>   Medicaid only<sup>c</sup></font></td>
<td><font>48.1</font></td>
<td><font>28.6</font></td>
</tr><tr><td scope="row"><font>   Both Private and Medicaid</font></td>
<td><font>16.6</font></td>
<td><font>10.2</font></td>
</tr><tr><td scope="row"><font>   Other<sup>d</sup></font></td>
<td><font>9.2</font></td>
<td><font>12.4</font></td>
</tr><tr><td scope="row"><font>No Medicare  			 Supplemental Coverage  </font></td>
<td><font>6.6</font></td>
<td><font>9.5</font></td>
</tr><tr><td colspan="3" scope="row"><font>Any Medicare Covered Nursing Home Stay</font></td>
</tr><tr><td scope="row"><font>   Yes</font></td>
<td><font>25.6</font></td>
<td><font>22.7</font></td>
</tr><tr><td scope="row"><font>   No</font></td>
<td><font>74.4</font></td>
<td><font>77.3</font></td>
</tr><tr><td colspan="3" scope="row"><font>Lived in Community Any Time During the Year</font></td>
</tr><tr><td scope="row"><font>   Yes</font></td>
<td><font>25.7</font></td>
<td><font>34.7</font></td>
</tr><tr><td scope="row"><font>   No</font></td>
<td><font>74.3</font></td>
<td><font>65.3</font></td>
</tr><tr><td colspan="3" scope="row"><font>Died During the Year</font></td>
</tr><tr><td scope="row"><font>   Yes</font></td>
<td><font>25.8</font></td>
<td><font>15.3</font></td>
</tr><tr><td scope="row"><font>   No</font></td>
<td><font>74.2</font></td>
<td><font>84.7</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, Institutional  			 Drug File, 1998 * Estimate not reliable as cell size &lt;20. </font><br /><ol type="a"><li><font>Includes assisted living facility, domiciliary  				  care home, personal care home, life care facility, continuing care retirement  				  community, retirement home.</font></li>
<li><font>Includes employer sponsored plan, individual  				  Medigap plan, Medicare HMO, private HMO.</font></li>
<li><font>Includes regular Medicaid and Qualified  				  Medicare Beneficiary (QMB) and Specified Low-Income Medicare Beneficiary (SLMB)  				  Plus programs.</font></li>
<li><font>Includes public plans (such as Veterans  				  Affairs, Department of Defense, State Pharmaceutical Assistance Programs) and  				  combinations, and evidence of some coverage but source not  				  reported.</font></li>
</ol></td>
</tr></table><table title="TABLE 2&gt;. Institutional Medicare Beneficiaries by Type of Facility Stay and Resident Health Status, 1998"><tr><td colspan="3"><font><b><a name="table2" id="table2">TABLE 2</a>. Institutional Medicare  			 Beneficiaries by Type of Facility Stay and Resident Health Status,  			 1998</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font><b>Beneficiary  			 Characteristics</b></font></td>
<td colspan="2" scope="col"><font><b>Percent  			 Beneficiaries</b></font></td>
</tr><tr><td scope="col"><font><b>  Any Nursing  Facility  			 Stay</b></font></td>
<td scope="col"><font><b>  Any Assisted Living  			 or  Related Facility Stay<sup>a</sup></b></font></td>
</tr><tr><td scope="row"><font>Total</font></td>
<td><font>1,905,487</font></td>
<td><font>638,596</font></td>
</tr><tr><td colspan="3" scope="row"><font>General Health Status</font></td>
</tr><tr><td scope="row"><font>   Excellent to good  </font></td>
<td><font>31.4</font></td>
<td><font>51.0</font></td>
</tr><tr><td scope="row"><font>   Fair</font></td>
<td><font>45.7</font></td>
<td><font>31.0</font></td>
</tr><tr><td scope="row"><font>   Poor</font></td>
<td><font>20.2</font></td>
<td><font>15.6</font></td>
</tr><tr><td colspan="3" scope="row"><font>Reported Medical Conditions</font></td>
</tr><tr><td scope="row"><font>    Dementia/Alzheimer's</font></td>
<td><font>42.5</font></td>
<td><font>28.9</font></td>
</tr><tr><td scope="row"><font>   Other mental disorders  </font></td>
<td><font>40.4</font></td>
<td><font>37.7</font></td>
</tr><tr><td scope="row"><font>   Heart disease</font></td>
<td><font>41.6</font></td>
<td><font>31.4</font></td>
</tr><tr><td scope="row"><font>   Hypertension</font></td>
<td><font>37.7</font></td>
<td><font>39.1</font></td>
</tr><tr><td scope="row"><font>   Arthritis</font></td>
<td><font>30.0</font></td>
<td><font>17.1</font></td>
</tr><tr><td scope="row"><font>   Stroke</font></td>
<td><font>19.5</font></td>
<td><font>12.4</font></td>
</tr><tr><td scope="row"><font>   Diabetes</font></td>
<td><font>18.4</font></td>
<td><font>16.1</font></td>
</tr><tr><td scope="row"><font>   Chronic lung disease</font></td>
<td><font>12.3</font></td>
<td><font>9.1</font></td>
</tr><tr><td scope="row"><font>   Osteoporosis</font></td>
<td><font>10.7</font></td>
<td><font>12.8</font></td>
</tr><tr><td scope="row"><font>   Cancer</font></td>
<td><font>9.7</font></td>
<td><font>8.5</font></td>
</tr><tr><td scope="row"><font>   Hip fracture</font></td>
<td><font>6.0</font></td>
<td><font>3.8*</font></td>
</tr><tr><td colspan="3" scope="row"><font>Activities of Daily Living (ADL) Limitation</font></td>
</tr><tr><td scope="row"><font>   0</font></td>
<td><font>7.6</font></td>
<td><font>23.2</font></td>
</tr><tr><td scope="row"><font>   1-2</font></td>
<td><font>20.2</font></td>
<td><font>29.5</font></td>
</tr><tr><td scope="row"><font>   3-4</font></td>
<td><font>17.7</font></td>
<td><font>12.5</font></td>
</tr><tr><td scope="row"><font>   5-6</font></td>
<td><font>54.6</font></td>
<td><font>34.9</font></td>
</tr><tr><td colspan="3" scope="row"><font>Evidence of Urinary Incontinence</font></td>
</tr><tr><td scope="row"><font>   None</font></td>
<td><font>39.2</font></td>
<td><font>55.7</font></td>
</tr><tr><td scope="row"><font>   Any</font></td>
<td><font>60.8</font></td>
<td><font>44.3</font></td>
</tr><tr><td colspan="3" scope="row"><font>Evidence of Memory Loss</font></td>
</tr><tr><td scope="row"><font>   None</font></td>
<td><font>54.6</font></td>
<td><font>44.8</font></td>
</tr><tr><td scope="row"><font>   Any</font></td>
<td><font>45.4</font></td>
<td><font>55.2</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, Institutional  			 Drug File, 1998 * Estimate not reliable as cell size &lt;20. </font><br /><ol type="a"><li><font>Includes assisted living facility, domiciliary  				  care home, personal care home, life care facility, continuing care retirement  				  community, retirement home.</font></li>
<li><font>Includes depression, schizophrenia, psychosis  				  and other mental disorders.</font></li>
</ol></td>
</tr></table><table title="TABLE 3. Mean Number of Drug Mentions per Month for Institutionalized Medicare Beneficiaries by Type of Facility Stay, 1998"><tr><td colspan="3"><font><b><a name="table3" id="table3">TABLE 3</a>. Mean Number of Drug  			 Mentions<sup>a</sup> per Month for Institutionalized Medicare Beneficiaries by  			 Type of Facility Stay, 1998</b></font></td>
</tr><tr><td scope="col"><font> </font></td>
<td scope="col"><font><b>  Any Nursing  Facility  			 Stay</b></font></td>
<td scope="col"><font><b>  Any Assisted Living  			 or  Related Facility Stay<sup>b</sup></b></font></td>
</tr><tr><td scope="row"><font>Total</font></td>
<td><font>1,905,487</font></td>
<td><font>638,596</font></td>
</tr><tr><td scope="row"><font>Mean total  			 drug mentions per month</font></td>
<td><font>8.1</font></td>
<td><font>7.5</font></td>
</tr><tr><td scope="row"><font>Percent  			 beneficiaries under scheduled drugs</font></td>
<td><font>99.0%</font></td>
<td><font>98.2%</font></td>
</tr><tr><td scope="row"><font>   Mean scheduled drug mentions per  			 month  </font></td>
<td><font>7.3</font></td>
<td><font>6.9</font></td>
</tr><tr><td scope="row"><font>Percent  			 beneficiaries using PRN drugs</font></td>
<td><font>73.0%</font></td>
<td><font>62.6%</font></td>
</tr><tr><td scope="row"><font>   Mean PRN drug mentions per month</font></td>
<td><font>1.2</font></td>
<td><font>1.1</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, Institutional  			 Drug File, 1998 </font><br /><ol type="a"><li><font>Only those drugs that were administered at  				  least once in the month were counted.</font></li>
<li><font>Includes assisted living facility, domiciliary  				  care home, personal care home, life care facility, continuing care retirement  				  community, retirement home.</font></li>
</ol></td>
</tr></table><table title="TABLE 4. Frequency Distribution of Mean Number of Drug Mentions per Month for Institutionalized Medicare Beneficiaries by Type of Facility Stay, 1998"><tr><td colspan="3"><font><b><a name="table4" id="table4">TABLE 4</a>. Frequency Distribution of Mean  			 Number of Drug Mentions<sup>a</sup> per Month for Institutionalized Medicare  			 Beneficiaries by Type of Facility Stay, 1998</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font> </font></td>
<td colspan="2" scope="col"><font><b>Percent  			 Beneficiaries</b></font></td>
</tr><tr><td scope="col"><font><b>  Any Nursing  Facility  			 Stay</b></font></td>
<td scope="col"><font><b>  Any Assisted Living  			 or  Related Facility Stay<sup>b</sup></b></font></td>
</tr><tr><td colspan="3" scope="row"><font>Mean Total Drug Mentions Per Month for Users</font></td>
</tr><tr><td scope="row"><font>   1 - &lt;3</font></td>
<td><font>7.2%</font></td>
<td><font>12.2%</font></td>
</tr><tr><td scope="row"><font>   3 - &lt;6</font></td>
<td><font>23.2</font></td>
<td><font>29.2</font></td>
</tr><tr><td scope="row"><font>   6 - &lt;9</font></td>
<td><font>30.4</font></td>
<td><font>24.7</font></td>
</tr><tr><td scope="row"><font>   9 or more  </font></td>
<td><font>39.2</font></td>
<td><font>33.8</font></td>
</tr><tr><td colspan="3" scope="row"><font>Mean Scheduled Drug Mentions Per Month for Users</font></td>
</tr><tr><td scope="row"><font>   1 - &lt;3</font></td>
<td><font>8.7%</font></td>
<td><font>13.5%</font></td>
</tr><tr><td scope="row"><font>   3 - &lt;6</font></td>
<td><font>28.9</font></td>
<td><font>35.2</font></td>
</tr><tr><td scope="row"><font>   6 - &lt;9</font></td>
<td><font>33.2</font></td>
<td><font>25.0</font></td>
</tr><tr><td scope="row"><font>   9 or more</font></td>
<td><font>28.8</font></td>
<td><font>26.4</font></td>
</tr><tr><td colspan="3" scope="row"><font>Mean PRN Drug Mentions Per Month for Users </font></td>
</tr><tr><td scope="row"><font>   &lt;1</font></td>
<td><font>49.2%</font></td>
<td><font>53.1%</font></td>
</tr><tr><td scope="row"><font>   1 - &lt;2</font></td>
<td><font>26.5</font></td>
<td><font>28.2</font></td>
</tr><tr><td scope="row"><font>   2 - &lt;3</font></td>
<td><font>16.3</font></td>
<td><font>12.2</font></td>
</tr><tr><td scope="row"><font>   3 or more</font></td>
<td><font>8.0</font></td>
<td><font>6.5*</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, Institutional  			 Drug File, 1998* Estimate not reliable as cell size &lt;20. </font><br /><ol type="a"><li><font>Only those drugs that were administered at  				  least once in the month were counted.</font></li>
<li><font>Includes assisted living facility, domiciliary  				  care home, personal care home, life care facility, continuing care retirement  				  community, retirement home.</font></li>
</ol></td>
</tr></table><table title="TABLE 5. Mean Number of Drug Mentions per Month for Institutionalized Medicare Beneficiaries by Type of Facility Stay and Health Insurance Coverage, 1998"><tr><td colspan="3"><font><b><a name="table5" id="table5">TABLE 5</a>. Mean Number of Drug Mentions  			 per Month for Institutionalized Medicare Beneficiaries by Type of Facility Stay  			 and Health Insurance Coverage, 1998</b></font></td>
</tr><tr><td scope="col"><font><b>Health Insurance Coverage</b></font></td>
<td scope="col"><font><b>  Any Nursing  Facility  			 Stay</b></font></td>
<td scope="col"><font><b>  Any Assisted Living  			 or  Related Facility Stay<sup>a</sup></b></font></td>
</tr><tr><td scope="row"><font>Total</font></td>
<td><font>8.1</font></td>
<td><font>7.5</font></td>
</tr><tr><td colspan="3" scope="row"><font>Source of Medicare Supplemental Coverage </font></td>
</tr><tr><td scope="row"><font>   Private only<sup>b</sup></font></td>
<td><font>8.0</font></td>
<td><font>7.8</font></td>
</tr><tr><td scope="row"><font>   Medicaid only<sup>c</sup></font></td>
<td><font>8.1</font></td>
<td><font>6.8</font></td>
</tr><tr><td scope="row"><font>   Both Private and Medicaid  </font></td>
<td><font>8.7</font></td>
<td><font>9.1</font></td>
</tr><tr><td scope="row"><font>   Other<sup>d</sup></font></td>
<td><font>8.0</font></td>
<td><font>7.8</font></td>
</tr><tr><td scope="row"><font>No Medicare  			 Supplemental Coverage</font></td>
<td><font>7.8</font></td>
<td><font>6.2</font></td>
</tr><tr><td colspan="3" scope="row"><font>Any Medicare Covered SNF Stay</font></td>
</tr><tr><td scope="row"><font>   Yes</font></td>
<td><font>9.1</font></td>
<td><font>9.5</font></td>
</tr><tr><td scope="row"><font>   No</font></td>
<td><font>7.8</font></td>
<td><font>6.9</font></td>
</tr><tr><td colspan="3" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, Institutional  			 Drug File, 1998* Estimate not reliable as cell size &lt;20. </font><br /><ol type="a"><li><font>Includes assisted living facility, domiciliary  				  care home, personal care home, life care facility, continuing care retirement  				  community, retirement home.</font></li>
<li><font>Includes employer sponsored plan, individual  				  Medigap plan, Medicare HMO, private HMO.</font></li>
<li><font>Includes regular Medicaid and Qualified  				  Medicare Beneficiary (QMB) and Specified Low-Income Medicare Beneficiary (SLMB)  				  Plus programs.</font></li>
<li><font>Includes public plans (such as Veterans  				  Affairs, Department of Defense, State Pharmaceutical Assistance Programs) and  				  combinations, and evidence of some coverage but source not  				  reported.</font></li>
</ol></td>
</tr></table><table title="TABLE 6. Prevalence and Duration of Drugs Used by Medicare Beneficiaries in Nursing Facilities and Assisted Living and Related Facilities by Descending Order of Prevalence of Drug Class in Nursing Facilities, 1998"><tr><td colspan="5"><font><b><a name="table6" id="table6">TABLE 6</a>. Prevalence and Duration of  			 Drugs<sup>a</sup> Used by Medicare Beneficiaries in Nursing Facilities and  			 Assisted Living and Related Facilities<sup>b</sup> by Descending Order of  			 Prevalence of Drug Class in Nursing Facilities, 1998</b></font></td>
</tr><tr><td rowspan="2" scope="col"><font><b>Drug  			 Class<sup>c</sup></b></font></td>
<td colspan="2" scope="col"><font><b>Beneficiaries with  			 AnyNursing Facility Stay</b></font></td>
<td colspan="2" scope="col"><font><b>Beneficiaries with  			 AnyAssisted Living andRelated Facility Stay</b></font></td>
</tr><tr><td scope="col"><font><b>Percent of  Residents  			 with  Any Use</b></font></td>
<td scope="col"><font><b>For Users, Percentof Months  			 of  Residence in which  the Drug is  			 Used</b></font></td>
<td scope="col"><font><b>Percent of  Residents  			 with  Any Use</b></font></td>
<td scope="col"><font><b>For Users, Percentof Months  			 of  Residence in which  the Drug is  			 Used</b></font></td>
</tr><tr><td scope="row"><font>Analgesics and Antipyretics</font></td>
<td><font>81.5</font></td>
<td><font>74.7</font></td>
<td><font>71.3</font></td>
<td><font>78.9</font></td>
</tr><tr><td scope="row"><font>   Analgesics, Salicylates</font></td>
<td><font>30.4</font></td>
<td><font>86.0</font></td>
<td><font>29.3</font></td>
<td><font>89.7</font></td>
</tr><tr><td scope="row"><font>   Analgesics, Non-salicylates</font></td>
<td><font>60.8</font></td>
<td><font>53.5</font></td>
<td><font>47.1</font></td>
<td><font>60.3</font></td>
</tr><tr><td scope="row"><font>   Analygesics, NSAIDs</font></td>
<td><font>17.9</font></td>
<td><font>58.9</font></td>
<td><font>21.6</font></td>
<td><font>50.9</font></td>
</tr><tr><td scope="row"><font>   Analgesics, Narcotics</font></td>
<td><font>29.9</font></td>
<td><font>56.6</font></td>
<td><font>25.3</font></td>
<td><font>53.6</font></td>
</tr><tr><td scope="row"><font>Gastrointestinal Drugs</font></td>
<td><font>78.6</font></td>
<td><font>84.4</font></td>
<td><font>65.1</font></td>
<td><font>82.2</font></td>
</tr><tr><td scope="row"><font>   Cathartics and Laxatives</font></td>
<td><font>63.5</font></td>
<td><font>76.9</font></td>
<td><font>46.7</font></td>
<td><font>73.1</font></td>
</tr><tr><td scope="row"><font>  			    Anti-Ulcer Agents</font></td>
<td><font>32.8</font></td>
<td><font>80.7</font></td>
<td><font>29.4</font></td>
<td><font>77.1</font></td>
</tr><tr><td scope="row"><font>  			    Antacids and Adsorbents</font></td>
<td><font>16.2</font></td>
<td><font>51.1</font></td>
<td><font>13.2</font></td>
<td><font>39.7</font></td>
</tr><tr><td scope="row"><font>   Antidiarrhea Agents</font></td>
<td><font>9.9</font></td>
<td><font>29.0</font></td>
<td><font>12.4</font></td>
<td><font>37.2</font></td>
</tr><tr><td scope="row"><font>   Intestinal Motility Stimulants</font></td>
<td><font>8.8</font></td>
<td><font>71.9</font></td>
<td><font>5.9*</font></td>
<td><font>70.5</font></td>
</tr><tr><td scope="row"><font>Electrolytic, Caloric and Water Balance</font></td>
<td><font>73.8</font></td>
<td><font>88.0</font></td>
<td><font>63.0</font></td>
<td><font>87.9</font></td>
</tr><tr><td scope="row"><font>  			    Minerals and Vitamins</font></td>
<td><font>57.0</font></td>
<td><font>85.9</font></td>
<td><font>48.2</font></td>
<td><font>87.8</font></td>
</tr><tr><td scope="row"><font>  			    Electrolyte Balance</font></td>
<td><font>35.4</font></td>
<td><font>79.6</font></td>
<td><font>33.6</font></td>
<td><font>78.4</font></td>
</tr><tr><td scope="row"><font>  			    Nutritional Therapy</font></td>
<td><font>18.5</font></td>
<td><font>67.5</font></td>
<td><font>8.0</font></td>
<td><font>59.6</font></td>
</tr><tr><td scope="row"><font>Central Nervous System (CNS) Agents</font></td>
<td><font>70.2</font></td>
<td><font>86.6</font></td>
<td><font>69.3</font></td>
<td><font>91.1</font></td>
</tr><tr><td scope="row"><font>  			    Antidepressants</font></td>
<td><font>38.3</font></td>
<td><font>82.1</font></td>
<td><font>41.2</font></td>
<td><font>83.1</font></td>
</tr><tr><td scope="row"><font>   Anxiolytics, Sedatives, and Hypnotics</font></td>
<td><font>29.1</font></td>
<td><font>69.6</font></td>
<td><font>28.9</font></td>
<td><font>69.3</font></td>
</tr><tr><td scope="row"><font>   Antipsychotics</font></td>
<td><font>23.2</font></td>
<td><font>77.7</font></td>
<td><font>23.9</font></td>
<td><font>82.3</font></td>
</tr><tr><td scope="row"><font>   Anticonvulsants</font></td>
<td><font>14.7</font></td>
<td><font>86.6</font></td>
<td><font>13.4</font></td>
<td><font>87.0</font></td>
</tr><tr><td scope="row"><font>   Antiparkinsonism Agents</font></td>
<td><font>11.6</font></td>
<td><font>68.8</font></td>
<td><font>9.5</font></td>
<td><font>83.3</font></td>
</tr><tr><td scope="row"><font>   Anti-Alzheimer</font></td>
<td><font>4.9</font></td>
<td><font>76.9</font></td>
<td><font>8.8</font></td>
<td><font>87.2</font></td>
</tr><tr><td scope="row"><font>Anti-Infective Agents</font></td>
<td><font>63.5</font></td>
<td><font>38.6</font></td>
<td><font>50.8</font></td>
<td><font>40.5</font></td>
</tr><tr><td scope="row"><font>   Antibiotics</font></td>
<td><font>54.4</font></td>
<td><font>30.8</font></td>
<td><font>40.2</font></td>
<td><font>32.6</font></td>
</tr><tr><td scope="row"><font>   Antibacterials</font></td>
<td><font>14.8</font></td>
<td><font>26.4</font></td>
<td><font>12.1</font></td>
<td><font>31.2</font></td>
</tr><tr><td scope="row"><font>   Antifungal Agents</font></td>
<td><font>8.3</font></td>
<td><font>31.1</font></td>
<td><font>5.4*</font></td>
<td><font>51.8</font></td>
</tr><tr><td scope="row"><font>  			    Biologicals</font></td>
<td><font>4.7</font></td>
<td><font>19.6</font></td>
<td><font>4.4*</font></td>
<td><font>22.4</font></td>
</tr><tr><td scope="row"><font>  			    Antiparasitic Agents</font></td>
<td><font>3.4</font></td>
<td><font>40.1</font></td>
<td><font>3.0*</font></td>
<td><font>16.8</font></td>
</tr><tr><td scope="row"><font>  			    Antiviral Agents</font></td>
<td><font>3.1</font></td>
<td><font>16.8</font></td>
<td><font>1.6*</font></td>
<td><font>10.9</font></td>
</tr><tr><td scope="row"><font>   Antiseptics</font></td>
<td><font>2.7</font></td>
<td><font>73.6</font></td>
<td><font>3.0*</font></td>
<td><font>61.5</font></td>
</tr><tr><td scope="row"><font>Cardiovascular Agents</font></td>
<td><font>56.1</font></td>
<td><font>91.8</font></td>
<td><font>56.8</font></td>
<td><font>91.8</font></td>
</tr><tr><td scope="row"><font>   Ace-Inhibitors</font></td>
<td><font>22.1</font></td>
<td><font>81.6</font></td>
<td><font>21.5</font></td>
<td><font>86.0</font></td>
</tr><tr><td scope="row"><font>   Cardiac Stimulants</font></td>
<td><font>19.8</font></td>
<td><font>94.6</font></td>
<td><font>19.7</font></td>
<td><font>91.0</font></td>
</tr><tr><td scope="row"><font>  			    Calcium Channel Blockers</font></td>
<td><font>19.0</font></td>
<td><font>85.2</font></td>
<td><font>18.7</font></td>
<td><font>84.7</font></td>
</tr><tr><td scope="row"><font>   Vasodilators</font></td>
<td><font>17.3</font></td>
<td><font>80.6</font></td>
<td><font>13.7</font></td>
<td><font>79.9</font></td>
</tr><tr><td scope="row"><font>   Beta-Blockers</font></td>
<td><font>9.0</font></td>
<td><font>86.8</font></td>
<td><font>11.5</font></td>
<td><font>83.1</font></td>
</tr><tr><td scope="row"><font>  			    Sympatholytic Drugs</font></td>
<td><font>4.4</font></td>
<td><font>92.1</font></td>
<td><font>5.6*</font></td>
<td><font>64.2</font></td>
</tr><tr><td scope="row"><font>  			    Angiotensin Receptor Blockers</font></td>
<td><font>2.6</font></td>
<td><font>90.8</font></td>
<td><font>2.1*</font></td>
<td><font>94.7</font></td>
</tr><tr><td scope="row"><font>  			    Cholesterol and Triglyceride Lowering Agents</font></td>
<td><font>2.6</font></td>
<td><font>76.0</font></td>
<td><font>5.4*</font></td>
<td><font>81.3</font></td>
</tr><tr><td scope="row"><font>Ear/Eye/Nose/Rectum/Topical/Vagina/Other</font></td>
<td><font>49.6</font></td>
<td><font>64.4</font></td>
<td><font>44.2</font></td>
<td><font>68.0</font></td>
</tr><tr><td scope="row"><font>   Dermatologic Preparations</font></td>
<td><font>29.7</font></td>
<td><font>46.0</font></td>
<td><font>22.8</font></td>
<td><font>40.3</font></td>
</tr><tr><td scope="row"><font>   Eye Preparations</font></td>
<td><font>23.6</font></td>
<td><font>71.6</font></td>
<td><font>23.9</font></td>
<td><font>74.4</font></td>
</tr><tr><td scope="row"><font>   Nose Preparations</font></td>
<td><font>3.6</font></td>
<td><font>44.9</font></td>
<td><font>5.7*</font></td>
<td><font>46.9</font></td>
</tr><tr><td scope="row"><font>   Ear Preparations</font></td>
<td><font>2.4</font></td>
<td><font>22.0</font></td>
<td><font>4.8*</font></td>
<td><font>11.5</font></td>
</tr><tr><td scope="row"><font>   Benign Prostatic Hypertrophy Agents</font></td>
<td><font>4.3</font></td>
<td><font>77.9</font></td>
<td><font>5.3*</font></td>
<td><font>97.6</font></td>
</tr><tr><td scope="row"><font>Kidney/Urinary Tract Agents</font></td>
<td><font>46.3</font></td>
<td><font>83.3</font></td>
<td><font>45.2</font></td>
<td><font>83.4</font></td>
</tr><tr><td scope="row"><font>  			    Diuretics</font></td>
<td><font>43.3</font></td>
<td><font>83.5</font></td>
<td><font>40.0</font></td>
<td><font>86.8</font></td>
</tr><tr><td scope="row"><font>   Anti-incontinence/Antispasmodic Agents</font></td>
<td><font>4.9</font></td>
<td><font>66.0</font></td>
<td><font>5.0*</font></td>
<td><font>50.8</font></td>
</tr><tr><td scope="row"><font>Hormones and Synthetic Substitutes</font></td>
<td><font>41.7</font></td>
<td><font>84.6</font></td>
<td><font>43.1</font></td>
<td><font>90.8</font></td>
</tr><tr><td scope="row"><font>   Insulin and Anti-Diabetic Agents</font></td>
<td><font>16.7</font></td>
<td><font>92.9</font></td>
<td><font>15.8</font></td>
<td><font>93.2</font></td>
</tr><tr><td scope="row"><font>  			    Thyroid and Antithyroid Agents</font></td>
<td><font>14.2</font></td>
<td><font>95.2</font></td>
<td><font>16.3</font></td>
<td><font>96.6</font></td>
</tr><tr><td scope="row"><font>   Adrenocortical Hormones</font></td>
<td><font>9.2</font></td>
<td><font>55.5</font></td>
<td><font>9.5</font></td>
<td><font>75.8</font></td>
</tr><tr><td scope="row"><font>   Parathyroid/Bone Resorption Drugs</font></td>
<td><font>5.7</font></td>
<td><font>73.3</font></td>
<td><font>7.1</font></td>
<td><font>86.0</font></td>
</tr><tr><td scope="row"><font>   Female Hormonal Agents</font></td>
<td><font>5.1</font></td>
<td><font>68.6</font></td>
<td><font>8.2</font></td>
<td><font>77.4</font></td>
</tr><tr><td scope="row"><font>Respiratory Agents</font></td>
<td><font>40.9</font></td>
<td><font>46.6</font></td>
<td><font>33.4</font></td>
<td><font>49.5</font></td>
</tr><tr><td scope="row"><font>  			    Antitussives, Expectorants, Mucolytic Agents</font></td>
<td><font>27.1</font></td>
<td><font>29.1</font></td>
<td><font>22.3</font></td>
<td><font>31.1</font></td>
</tr><tr><td scope="row"><font>    Bronchodilators</font></td>
<td><font>19.0</font></td>
<td><font>62.9</font></td>
<td><font>12.7</font></td>
<td><font>72.4</font></td>
</tr><tr><td scope="row"><font>   Inhaled Steroids</font></td>
<td><font>6.0</font></td>
<td><font>63.4</font></td>
<td><font>5.0*</font></td>
<td><font>49.3</font></td>
</tr><tr><td scope="row"><font>Anti-Allergy Agents</font></td>
<td><font>18.3</font></td>
<td><font>41.6</font></td>
<td><font>12.3</font></td>
<td><font>44.5</font></td>
</tr><tr><td scope="row"><font>  			    Antihistamines</font></td>
<td><font>17.2</font></td>
<td><font>43.1</font></td>
<td><font>12.0</font></td>
<td><font>45.1</font></td>
</tr><tr><td scope="row"><font>Blood Formation and Coagulation Agents</font></td>
<td><font>17.3</font></td>
<td><font>76.5</font></td>
<td><font>10.0</font></td>
<td><font>85.9</font></td>
</tr><tr><td scope="row"><font>   Anticoagulants/Thrombolytics</font></td>
<td><font>16.1</font></td>
<td><font>78.1</font></td>
<td><font>9.2</font></td>
<td><font>87.0</font></td>
</tr><tr><td scope="row"><font>Anti-Cancer Agents</font></td>
<td><font>4.0</font></td>
<td><font>65.0</font></td>
<td><font>2.8*</font></td>
<td><font>76.3</font></td>
</tr><tr><td colspan="5" scope="row"><font><b>SOURCE</b>: Medicare Current Beneficiary Survey, Institutional  			 Drug File, 1998.* Estimate not reliable as cell size &lt;20. </font><br /><ol type="a"><li><font>Only those drugs that were administered at  				  least once in the month were counted.</font></li>
<li><font>Includes assisted living facility, domiciliary  				  care home, personal care home, life care facility, continuing care retirement  				  community, retirement home.</font></li>
<li><font>Drug classification is an adaptation of the HIC  				  therapeutic drug classification system, First Databank 2001 edition. Data on  				  drug sub-classes with prevalence of less than 2% in beneficiaries with any  				  nursing facility stay are not shown, but are included in the estimates of  				  overall prevalence and duration of each major drug class.</font></li>
</ol></td>
</tr></table><h2><a name="appendix" id="appendix">APPENDIX</a></h2>
<p><i>Study Sample</i>. The 1998 Medicare Current Beneficiary Survey (MCBS)  		Institutional Drug Administration (IDA) file contains information on 1553  		Medicare beneficiaries. Of these, 1260 beneficiaries have survey IDs in the  		1998 MCBS facility file and this group forms the sample for our analyses. Of  		the remaining 293 beneficiaries, 286 beneficiaries had survey responses from  		the 1997 MCBS facility files.</p>
<p><i>Type of Facilities</i>. The MCBS survey used a broad definition of  		long term facility care in order to capture a complete picture of all types of  		institutions providing care received by the Medicare population. The survey  		includes licensed nursing homes and other long term care facilities such as  		retirement homes, domiciliary or personal care facilities, mental health or  		mental retardation facilities, continuing care facilities, assisted living  		facilities, and rehabilitation facilities. To be included in the survey, a  		facility <b>must</b> have three or more long term care beds, and answer  		affirmatively to <b>at least one</b> of the following three questions: does  		this facility (1) provide personal care services to residents; (2) provide  		continuous supervision of residents; (3) provide any long term care. It must be  		noted that while the MCBS sample is representative of the Medicare population  		that uses long-term care facilities, it was not designed to be representative  		of the universe of long term care providers. Due to the primary sampling of the  		person sample in the MCBS, larger facilities have a greater chance of being  		included than small facilities, because at any one time there are more persons  		in a larger facility than in a smaller facility.</p>
<p><i>Institutional Stay</i>. We characterized the type of institutional  		stay according the facility descriptors collected in the survey. We defined  		assisted living or related facility (assisted living facility) stay as any stay  		in an assisted living facility, domiciliary care home, personal care home, life  		care facility, continuing care retirement community, or retirement home.  		Appendix <a href="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html#tableA1">table A1</a> presents a distribution of  		institutionalized beneficiaries by type of facility stay in 1998. We focused  		the analyses for this report on beneficiaries with any nursing home stay  		(N=910) or any assisted living facility stay (N=300) but excluded stays in  		mental health facilities, hospital and rehabilitation facilities, and other  		facilities because sample sizes in the 1998 MCBS are too small to adequately  		characterize these facility types.</p>
<p><i>Medications Administered</i>. The MCBS IDA file describes medications  		prescribed or administered to residents while institutionalized. Surveyors are  		instructed to record all medicines listed on the resident's medication chart  		regardless of whether the medicine was actually taken. This includes  		prescriptions given at regular intervals or those given as PRN or standing  		orders. As a result, the IDA file contains the names of some medicines never  		taken during the month. Medications listed but never given can be identified  		through fields indicating the frequency of administrations. In our analyses  		only drugs administered at least once during the month are included. We also  		excluded drug mentions that were classified as durable medical equipment,  		medical supplies/devices, and pharmaceutical adjuvants.</p>
<p><i>Health Status</i>. The MCBS survey gathers information on the health  		status and functioning of sample persons only once during the year (in the Fall  		interview round). The beneficiary's residence at that time determines whether  		the facility or community version of the health survey is given. In general,  		the facility health survey contains more detail than the community survey but  		they cover the same core of questions. To assess the health status of all  		residents, we identified a set of common questions in both surveys for this  		analysis. It should be noted that responses in the community health survey are  		self-reports while those from the facility interview are proxy responses from  		the medical chart and facility staff such as nurses. Seventy beneficiaries  		(7.7%) with a NH stay and 25 beneficiaries (8.3%) with an assisted living  		facility stay responded to the community health survey in 1998.</p>
<p><i>Therapeutic Drug Classes</i>. The IDA file captures only raw drug  		mentions with no therapeutic drug classification. For this analysis, we used a  		computerized matching algorithm to map the raw drug mentions to standardized  		drug names with specific drug classes. Drug mentions receiving no matches or  		multiple matches were manually reviewed and mapped by two pharmacists. We  		relied upon the FirstDataBank drug dictionary, 2001 edition, as the source for  		the standard drug names and drug classes. Our tables report the HIC3 drug class  		from the FirstDatabank.</p>
<p><i>Residence Histories</i>. The MCBS captures information on changes in  		the living situations of beneficiaries during the year. We used these situation  		codes to create detailed residence histories for each beneficiary. This  		information allowed us to track residents as they moved from the community to  		the facility, from facility to facility, or from facility to death. Monthly  		drug use was mapped to these residence histories to create estimates of mean  		drug use per person month while in each facility type. Partial months are  		counted the same as full months in these analyses.</p>
<table title="TABLE A1. Distribution of Beneficiaries in the 1998 MCBS Facility Sample with Institutional Drug Administrations by Type of Facility Stay"><tr><td colspan="3"><font><b><a name="tableA1" id="tableA1">TABLE A1</a>. Distribution of  			 Beneficiaries in the 1998 MCBS Facility Sample with Institutional Drug  			 Administrations by Type of Facility Stay(unweighted counts)</b></font></td>
</tr><tr><td scope="col"><font><b>Type of Facility Stay</b></font></td>
<td scope="col"><font> </font></td>
<td scope="col"><font><b> N</b></font></td>
</tr><tr><td scope="row"><font>Any Nursing  			 Home (NH) Stay</font></td>
<td><font> </font></td>
<td><font>  910  </font></td>
</tr><tr><td scope="row"><font>   Only NH stay</font></td>
<td><font>  874  </font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   NH and assisted living facility</font></td>
<td><font>28</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   NH and MH</font></td>
<td><font>5</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   NH and hospital</font></td>
<td><font>1</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   NH and rehab/other</font></td>
<td><font>1</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   NH and MH and rehab/other</font></td>
<td><font>1</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>Any Assisted  			 Living or Related Facility (assisted living facility)<sup>a</sup>  			 Stay  </font></td>
<td><font>  </font></td>
<td><font>300</font></td>
</tr><tr><td scope="row"><font>   Only assisted living facility stay</font></td>
<td><font>267</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   Assisted living facility and NH</font></td>
<td><font>28</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   Assisted living facility and MH</font></td>
<td><font>5</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>Any Mental  			 Health Facility (MH)<sup>b</sup> Stay</font></td>
<td><font>  </font></td>
<td><font>55</font></td>
</tr><tr><td scope="row"><font>   Only MH stay</font></td>
<td><font>44</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   MH and NH</font></td>
<td><font>5</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   MH and assisted living facility</font></td>
<td><font>5</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   MH and NH and rehab/other</font></td>
<td><font>1</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>Any  			 Hospital<sup>c</sup> (with Nursing Home Unit) Stay </font></td>
<td><font> </font></td>
<td><font>30</font></td>
</tr><tr><td scope="row"><font>   Only hospital stay</font></td>
<td><font>29</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   Hospital and NH</font></td>
<td><font>1</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>Any  			 Rehabilitation Facility or Other (Rehab/Other) Stay</font></td>
<td><font>  </font></td>
<td><font>6</font></td>
</tr><tr><td scope="row"><font>   Only rehab/other stay</font></td>
<td><font>4</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   Rehab/other and NH</font></td>
<td><font>1</font></td>
<td><font> </font></td>
</tr><tr><td scope="row"><font>   Rehab/other and NH and MH</font></td>
<td><font>1</font></td>
<td><font> </font></td>
</tr><tr><td colspan="3" scope="row">
<ol type="a"><li><font>Includes assisted living facility, domiciliary  				  care home, personal care home, life care facility, continuing care retirement  				  community, retirement home.</font></li>
<li><font>Includes mental health facility, institute for  				  the mentally retarded/developmentally disabled, mental health  				  center.</font></li>
<li><font>Includes Medicare-certified nursing home units  				  based within acute care hospitals; private psychiatric hospitals; state or  				  county hospitals for the mentally ill; Veterans Affairs hospitals and medical  				  centers; state hospitals for the mentally retarded; chronic disease,  				  rehabilitation, geriatric, and other long-term care hospitals; and other places  				  that are commonly called hospitals.</font></li>
</ol></td>
</tr></table><table title="TABLE A2. Characteristics of Facilities from which Residents Sampled"><tr><td colspan="3"><font><b><a name="tableA2" id="tableA2">TABLE A2</a>. Characteristics of  			 Facilities from which Residents Sampled</b></font></td>
</tr><tr><td scope="col"><font><b>Characteristics</b></font></td>
<td scope="col"><font><b>  Nursing  			 Facilities  </b></font></td>
<td scope="col"><font><b>  Assisted Living  			 and  Related Facilities<sup>a</sup></b></font></td>
</tr><tr><td scope="row"><font>Total  			 (N)</font></td>
<td><font>727</font></td>
<td><font>267</font></td>
</tr><tr><td colspan="3" scope="row"><font>Bed Size</font></td>
</tr><tr><td scope="row"><font>   10 and less</font></td>
<td><font>3.2%</font></td>
<td><font>17.6%</font></td>
</tr><tr><td scope="row"><font>   11-25</font></td>
<td><font>2.1</font></td>
<td><font>13.9</font></td>
</tr><tr><td scope="row"><font>   26-50</font></td>
<td><font>4.5</font></td>
<td><font>10.9</font></td>
</tr><tr><td scope="row"><font>   51-100</font></td>
<td><font>26.3</font></td>
<td><font>21.0</font></td>
</tr><tr><td scope="row"><font>   101-150</font></td>
<td><font>30.7</font></td>
<td><font>17.2</font></td>
</tr><tr><td scope="row"><font>   More than 150  </font></td>
<td><font>33.3</font></td>
<td><font>19.5</font></td>
</tr><tr><td scope="row"><font>Mean Bed Size  			 (SD)</font></td>
<td><font>143.7  			 (105.5)</font></td>
<td><font>90.3 (89.9)</font></td>
</tr><tr><td colspan="3" scope="row"><font>Ownership</font></td>
</tr><tr><td scope="row"><font>   For-profit</font></td>
<td><font>70.4%</font></td>
<td><font>58.4%</font></td>
</tr><tr><td scope="row"><font>   Non-profit</font></td>
<td><font>24.4</font></td>
<td><font>37.5</font></td>
</tr><tr><td scope="row"><font>   Government</font></td>
<td><font>4.8</font></td>
<td><font>4.1</font></td>
</tr><tr><td scope="row"><font>    Other</font></td>
<td><font>0.4</font></td>
<td><font>0.0</font></td>
</tr><tr><td colspan="3" scope="row"><font>Census Region</font></td>
</tr><tr><td scope="row"><font>   Northeast</font></td>
<td><font>19.9%</font></td>
<td><font>19.9%</font></td>
</tr><tr><td scope="row"><font>   Midwest</font></td>
<td><font>33.0</font></td>
<td><font>25.8</font></td>
</tr><tr><td scope="row"><font>   South</font></td>
<td><font>31.0</font></td>
<td><font>33.3</font></td>
</tr><tr><td scope="row"><font>   West</font></td>
<td><font>15.4</font></td>
<td><font>18.7</font></td>
</tr><tr><td colspan="3" scope="row"><font>Supervision of Medications</font></td>
</tr><tr><td scope="row"><font>   Yes</font></td>
<td><font>83.5%</font></td>
<td><font>88.8%</font></td>
</tr><tr><td scope="row"><font>   Unknown</font></td>
<td><font>16.5</font></td>
<td><font>11.2</font></td>
</tr><tr><td colspan="3" scope="row"><font>24-Hour Nursing Care</font></td>
</tr><tr><td scope="row"><font>   Yes</font></td>
<td><font>96.6%</font></td>
<td><font>37.5%</font></td>
</tr><tr><td scope="row"><font>   Unknown</font></td>
<td><font>3.4</font></td>
<td><font>62.5</font></td>
</tr><tr><td colspan="3" scope="row">
<ol type="a"><li><font>Includes assisted living facility, domiciliary  				  care home, personal care home, life care facility, continuing care retirement  				  community, retirement home.</font></li>
</ol></td>
</tr></table><hr /><h3><b><i>PRESCRIPTION DRUGS AND PEOPLE WITH DISABILITIES: A PRIMER FOR  		DATA AND RESEARCH</i> REPORTS AVAILABLE</b></h3>
<dl><dt> <b>Medication Use by Medicare Beneficiaries Living in Nursing Homes  		  and Assisted Living Facilities</b></dt>
<dd> HTML   <a href="http://aspe.hhs.gov/daltcp/reports/2002/meduse.htm">http://aspe.hhs.gov/daltcp/reports/2002/meduse.htm</a></dd>
<dd> PDF   <a href="https://s3-sa-east-1.amazonaws.com/ea-web-scrapes/aspe.hhs.gov/system/files/pdf/73256/meduse.pdf">http://aspe.hhs.gov/daltcp/reports/2002/meduse.pdf</a></dd>
</dl><dl><dt><b>Medication Use in Long-Term Care Facilities and Community Settings  		  for Medicare Beneficiaries with Cardiovascular Disease</b></dt>
<dd>Full HTML Version   <a href="http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.htm">http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.htm</a></dd>
<dd>Full PDF Version   <a href="http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.pdf">http://aspe.hhs.gov/daltcp/reports/2002/cdmeduse.pdf</a></dd>
</dl><dl><dt> <b>The Graying of Medicare's Disabled Population: Implication for a  		  Medicare Drug Benefit</b></dt>
<dd> Executive Summary   <a href="http://aspe.hhs.gov/daltcp/reports/2002/grayinges.htm">http://aspe.hhs.gov/daltcp/reports/2002/grayinges.htm</a></dd>
<dd> HTML   <a href="http://aspe.hhs.gov/daltcp/reports/2002/graying.htm">http://aspe.hhs.gov/daltcp/reports/2002/graying.htm</a></dd>
<dd> PDF   <a href="http://aspe.hhs.gov/daltcp/reports/2002/graying.pdf">http://aspe.hhs.gov/daltcp/reports/2002/graying.pdf</a></dd>
</dl><hr /><p>To obtain a printed copy of this report, send the full report title and  		your mailing information to:</p>
<blockquote><p>U.S. Department of Health and Human ServicesOffice of Disability,  		  Aging and Long-Term Care PolicyRoom 424E, H.H. Humphrey Building200  		  Independence Avenue, S.W.Washington, D.C.  		  20201FAX:  202-401-7733Email:  <a href="mailto: webmaster.DALTCP@hhs.gov">webmaster.DALTCP@hhs.gov</a></p>
</blockquote>
<hr /><p class="lastupdated"><b>RETURN TO:</b></p>
<p class="lastupdated">Office of Disability, Aging and  		Long-Term Care Policy (DALTCP) Home [<a href="../_/office_specific/daltcp.cfm.html">http://aspe.hhs.gov/_/office_specific/daltcp.cfm</a>]Assistant  		Secretary for Planning and Evaluation (ASPE) Home [<a href="../index.html">http://aspe.hhs.gov</a>]U.S. Department of  		Health and Human Services Home [<a href="http://www.hhs.gov">http://www.hhs.gov</a>]</p>

  <div class="download_report">

                        <div class="pdf-prev">
                <img src="https://aspe.hhs.gov/system/files/pdfpreview/e49408d0d73baa3078f398340e61a413.png" alt="Preview" title="Preview" />            </div>
                <a class="btn btn-sm btn-default download-file"
           href="https://s3-sa-east-1.amazonaws.com/ea-web-scrapes/aspe.hhs.gov/system/files/pdf/73256/meduse.pdf">Download</a>

        <p class="download_title">&quot;meduse.pdf&quot;
            (pdf,
            1.61Mb)</p>
        <p>Note: Documents in PDF format require the <a href="http://www.adobe.com/products/acrobat/readstep2.html">Adobe
                Acrobat Reader&reg;</a>. If you experience problems with PDF documents, please <a
                href="http://www.adobe.com/products/acrobat/readstep2.html">download the latest version of the
                Reader&reg;</a>
        </p>
    </div>
<div class="group-tags"><div class="field-label">Tags:&nbsp;</div><a href="../terms/assisted-livingcongregate-care.html">Assisted Living/Congregate Care</a><a href="../terms/publications-2.html">Publications</a><a href="../terms/assisted-livingresidential-care.html">Assisted Living/Residential Care</a><a href="../terms/nursing-home-financing-and-quality.html">Nursing Home Financing and Quality</a><a href="../terms/disability-aging-and-long-term-care-research.html">Disability, Aging and Long-Term Care Research</a><a href="../terms/highlighted-issues.html">Highlighted Issues</a><a href="../taxonomy/term/16236.1.html">Health Services, Formal</a></div>  </div>

      <footer>
          </footer>

    <div id="block-webform-client-block-158521" class="widget block block-webform" >


  <div id="webform-ajax-wrapper-158521"><form class="webform-client-form webform-client-form-158521" action="medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities.html" method="post" id="webform-client-form-158521" accept-charset="UTF-8"><div><div class="webform-progressbar">



  </div>
<div  class="form-item webform-component webform-component-radios webform-component--was-this-page-helpful">
  <label for="edit-submitted-was-this-page-helpful">Was this page helpful? <span class="form-required" title="This field is required.">*</span></label>
 <div id="edit-submitted-was-this-page-helpful" class="form-radios"><div class="form-type-radio form-item-submitted-was-this-page-helpful form-item radio">
 <input required="required" type="radio" id="edit-submitted-was-this-page-helpful-1" name="submitted[was_this_page_helpful]" value="1" class="form-radio" />  <label for="edit-submitted-was-this-page-helpful-1">Yes </label>

</div>
<div class="form-type-radio form-item-submitted-was-this-page-helpful form-item radio">
 <input required="required" type="radio" id="edit-submitted-was-this-page-helpful-2" name="submitted[was_this_page_helpful]" value="0" class="form-radio" />  <label for="edit-submitted-was-this-page-helpful-2">No </label>

</div>
</div>
</div>
<input type="hidden" name="details[sid]" />
<input type="hidden" name="details[page_num]" value="1" />
<input type="hidden" name="details[page_count]" value="4" />
<input type="hidden" name="details[finished]" value="0" />
<input type="hidden" name="form_build_id" value="form-VCe9pT2L0i5D5xmF-2Ttoau-pPBryOZeql63aPlaVMs" />
<input type="hidden" name="form_id" value="webform_client_form_158521" />
<input type="hidden" name="webform_ajax_wrapper_id" value="webform-ajax-wrapper-158521" />
<div class="form-actions"><input class="webform-next button-primary btn btn-default form-submit" type="submit" id="edit-webform-ajax-next-158521" name="op" value="Next &gt;" /></div>
<div class="is-useful-disclaimer"> <a href="https://aspe.hhs.gov/%23" class="" title="Survey Disclaimer" data-toggle="modal" data-target="#disclamerModal">Form Approved OMB# 0990-0379 Exp. Date 8/31/2017</a></div>
<div class="modal fade" id="disclamerModal" tabindex="-1" role="dialog" aria-labelledby="disclamerModalLabel">
  <div class="modal-dialog" role="document">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close" data-dismiss="modal" aria-label="Close"><span aria-hidden="true">&times;</span></button>
        <h2 class="modal-title" id="disclamerModalLabel">Survey Disclaimer</h2>
      </div>
      <div class="modal-body">
         According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-0379. The time required to complete this information collection is estimated to average 5 minutes per response, including the time to review instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer.      </div>
    </div>
  </div>
</div></div></form></div>
  </div> <!-- /.block -->
<meta  itemscope="" itemid="https://aspe.hhs.gov/pdf-report/medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities" itemref="md1" /><meta  itemscope="" itemid="https://aspe.hhs.gov/basic-report/medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities" itemref="md2 md3 md5 md7 md9 md11 md13 md15 md17" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/assisted-livingcongregate-care" id="md5" itemref="md4" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/publications-2" id="md7" itemref="md6" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/assisted-livingresidential-care" id="md9" itemref="md8" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/nursing-home-financing-and-quality" id="md11" itemref="md10" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/disability-aging-and-long-term-care-research" id="md13" itemref="md12" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/highlighted-issues" id="md15" itemref="md14" /><meta  itemscope="" itemid="https://aspe.hhs.gov/terms/health-services-formal" id="md17" itemref="md16" />
                          </div>










      </div>

          </div>


      </div>



      <footer  class="nd-region">



          <div class = "container">

      <div  class="row" id="Footer">










                                    <div  id="footer_sitemap-footer_sitemap" class="col-sm-6 col-md-6 col-lg-4 ">

                              <div id="block-footer-sitemap-footer-sitemap" class="widget block block-footer-sitemap" >


  <div id="footer-sitemap" class="clearfix">
  <div class="fs-block-content"><div class="menu-footer-utility"><ul class="footer_links_menu-footer-utility total-items-2 parent-items-0 single-items-0"><li class="menu-5021 depth-1 total-children-8 parent-children-0 single-children-8  first"><a href="../images/exit_disclaimer.jpg.html" title="look at ASPE Home" class="fs-root-link">ASPE Home</a><ul class="footer_links_menu-footer-utility total-items-8 parent-items-0 single-items-0"><li class="menu-5026 depth-1 fs-no-children  first"><a href="http://www.hhs.gov/" title="look at HHS Home">HHS Home</a></li>
<li class="menu-66281 depth-1 fs-no-children"><a href="http://www.usa.gov/" title="look at USA.gov">USA.gov</a></li>
<li class="menu-66316 depth-1 fs-no-children"><a href="https://oig.hhs.gov/" title="look at Office of the Inspector General">Office of the Inspector General</a></li>
<li class="menu-66321 depth-1 fs-no-children"><a href="http://www.whitehouse.gov" title="look at The White House">The White House</a></li>
<li class="menu-5046 depth-1 fs-no-children"><a href="http://www.hhs.gov/Accessibility.html" title="look at Accessibility">Accessibility</a></li>
<li class="menu-66326 depth-1 fs-no-children"><a href="http://www.hhs.gov/about/budget/index.html" title="look at Budget/Performance">Budget/Performance</a></li>
<li class="menu-2551 depth-1 fs-no-children"><a href="http://www.hhs.gov/Privacy.html" title="look at Privacy Policy">Privacy Policy</a></li>
<li class="menu-197776 depth-1 fs-no-children  last"><a href="https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html" title="Nondiscrimination Notice">Nondiscrimination Notice</a></li>
</ul></li>
<li class="menu-5051 depth-1 total-children-4 parent-children-0 single-children-4  last"><a href="http://www.hhs.gov/foia/" title="look at FOIA" class="fs-root-link">FOIA</a><ul class="footer_links_menu-footer-utility total-items-4 parent-items-0 single-items-0"><li class="menu-5056 depth-1 fs-no-children  first"><a href="http://www.hhs.gov/open/recordsandreports/plainwritingact/index.html" title="look at Plain Writing Act">Plain Writing Act</a></li>
<li class="menu-5061 depth-1 fs-no-children"><a href="http://www.hhs.gov/asa/eeo/no_fear_bullet_3.html" title="look at No Fear Act">No Fear Act</a></li>
<li class="menu-5066 depth-1 fs-no-children"><a href="http://www.hhs.gov/Disclaimer.html" title="look at Disclaimers">Disclaimers</a></li>
<li class="menu-2546 depth-1 fs-no-children  last"><a href="http://www.hhs.gov/plugins.html" title="look at Viewers &amp; Players">Viewers &amp; Players</a></li>
</ul></li>
</ul></div>
</div>
</div>

  </div> <!-- /.block -->

                          </div>


                                    <div  class="col-sm-6 col-md-6 col-lg-5 " id="stability_cms-contact_us">

                              <div id="block-stability-cms-contact-us" class="widget block block-stability-cms" >


  <div class="contacts-widget widget widget__footer">
	<div class="widget-content">
		<ul class="contacts-info-list">
      			<li>
<!--				<i class="fa fa-map-marker">Address</i>-->
                <div class="info-icons">
                    <img  alt="map" class= 'map-icons' src="../sites/all/themes/stability/stability_aspe/images/map.png"/>
                </div>
                <div class="info-item">
					Assistant Secretary for Planning and Evaluation, Room 415F<br />
U.S. Department of Health and Human Services<br />
200 Independence Avenue, SW<br />
Washington, D.C. 20201				</div>
			</li>
            			<li>
<!--				<i class="fa fa-phone">phone</i>-->
                <div class="info-icons">
                    <img alt="phone" src="../sites/all/themes/stability/stability_aspe/images/phone.png"/>
                </div>
				<div class="info-item">
					+1 202.690.7858				</div>
			</li>
            			<li>
<!--				<i class="fa fa-envelope">email</i>-->
                <div class="info-icons">
                    <img alt="mail" src="../sites/all/themes/stability/stability_aspe/images/mail-white.png"/>
                </div>
				<span class="info-item">
					<a href="mailto:osaspeinfo@hhs.gov">osaspeinfo@hhs.gov</a>
				</span>
			</li>
      			                					</ul>
	</div>
</div>
  </div> <!-- /.block -->

                          </div>


                                    <div  class="col-sm-6 col-md-6 col-lg-3 " id="footer">

                              <div id="block-block-36" class="widget block block-block" >

        <div class="title-accent">
			<h3 class = "widget-title" ><span>Sign-up</span> for Email Updates</h3>
		</div>

  <div class="email_updates">
<button class="btn btn-default" name="subscribe-button" type="submit" value="subscribe">subscribe</button>
</div>
  </div> <!-- /.block -->

                          </div>


                                    <div  class="col-sm-6 col-md-6 col-lg-12 " id="menu-menu-footer-language-menu">

                              <div id="block-menu-menu-footer-language-menu" class="widget block block-menu" >

        <div class="title-accent">
			<h3 class = "widget-title" ><span>Language</span> Assistance Available</h3>
		</div>

  <ul class="menu"><li class="first expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#spanish" title="Español">Español</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#chinese" title="繁體中文">繁體中文</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#vietnamese" title="Tiếng Việt">Tiếng Việt</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#korean" title="한국어">한국어</a></li>
</ul></li>
<li class="expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#tagalog" title="Tagalog">Tagalog</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#russian" title="Русский">Русский</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#arabic" title="العربية">العربية</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#creole" title="Kreyòl Ayisyen">Kreyòl Ayisyen</a></li>
</ul></li>
<li class="expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#french" title="Français">Français</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#polish" title="Polski">Polski</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#portuguese" title="Português">Português</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#italian" title="Italiano">Italiano</a></li>
</ul></li>
<li class="last expanded"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#german" title="Deutsch">Deutsch</a><ul><li class="first leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#japanese" title="日本語">日本語</a></li>
<li class="leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#farsi" title="فارسی">فارسی</a></li>
<li class="last leaf"><a href="https://www.hhs.gov/civil-rights/for-individuals/language-assistance/index.html#english" title="English">English</a></li>
</ul></li>
</ul>
  </div> <!-- /.block -->

                          </div>


      </div>

          </div>


      </footer>


    <!--/PAGEWATCH-->
    <div class="footer-copyright">
      <div class="container">
        <div class="row">
          <div class="col-sm-6 col-md-4">
                        </div>
          <div class="col-sm-6 col-md-8">
            <div class="social-links-wrapper">
              <span class="social-links-txt">Connect with us</span>
              <ul class="social-links social-links__dark">
                                                  <li><a href="http://twitter.com/hhs_aspe"><img alt="twitter" src="../sites/all/themes/stability/stability_aspe/images/tw-grey.png"/></a></li>
                                <!--                --><!--                  <li><a href="http://--><!--"><img alt="linkedin" src="--><!--/images/linkedin-grey.png"/></a></li>-->
<!--                -->
                                                              </ul>
            </div>
          </div>
        </div>
      </div>
    </div>

  </div>
</div>  <script type="text/javascript" src="../sites/default/files/advagg_js/js__VWRymaMz6HfrhnrcJNGcDiSvLVrvhaXvBa7nrBYy8gc__jntPwP3D6myJZH1jW19fXrk5cYMHGRL8NQION22VSEA__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="https://s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5486d15a696bff0c"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__g6mKbcakHxQkz4ZHYaxdO_xqONINvRMgsHh1zAK-fr0__ATHtEmHaeZ0jidpGU22EkhmPDBSgjD8z0bVDQMI-BIY__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__KUp4PrfOt9BSXUVl8Ctb3dhCMBe4MNVMeb4Gyorx8yY__7g4BeXscCIZAfuu1vxsCj2RIemg-eEK0QpChP9LDmFQ__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__PNjAgubM_3xXRLp4uLsYnv8wQAdT89-RYkSPxT6T45c__rFQwFK4pA5ZaWZSF7FPTfKbbpus0h-5IS8ayrNZGrb4__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__vQiLul2UcfC4nBAR09mhYVBYzRmiNDm2dj3GgSubV38__w84oZe-ZODKe7XnnlbrjV4IWHISOy4PioFEMVgx9hZo__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript" src="../sites/default/files/advagg_js/js__QJw3g0kOdwsv4twSZLP931zBzsHy50VEHpEN_znIitQ__A6QOuWXElDipBM2iChbWhjAAt3KlUwZ-jODoxdpbwiw__YASpjlMF4TMWgxnen_4K9EYMAww1U3QElt83Z7yKaXw.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"stability_aspe","theme_token":"hMrb0oXyPlUv1Vh9f6b_a3azvaIZ0SR6CUvg29bUa2M","jquery_version":"1.10","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.messages.css":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/css\/footable.css":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/css\/aspe_nodes.admin.css":1,"sites\/all\/modules\/custom\/aspe_views\/theme\/css\/aspe_views.admin.css":1,"sites\/all\/modules\/forked\/book\/book.css":1,"profiles\/openpublic\/modules\/contrib\/date\/date_api\/date.css":1,"profiles\/openpublic\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/contrib\/footer_sitemap\/footer_sitemap.css":1,"modules\/node\/node.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/extlink\/extlink.css":1,"profiles\/openpublic\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/media\/modules\/media_wysiwyg\/css\/media_wysiwyg.base.css":1,"sites\/all\/libraries\/datatables\/dataTables.responsive.css":1,"profiles\/openpublic\/modules\/contrib\/ctools\/css\/ctools.css":1,"profiles\/openpublic\/modules\/contrib\/panels\/css\/panels.css":1,"profiles\/openpublic\/modules\/contrib\/webform\/css\/webform.css":1,"sites\/default\/files\/css\/follow.css":1,"sites\/all\/themes\/stability\/css\/bootstrap.min.css":1,"sites\/all\/themes\/stability\/css\/fonts\/font-awesome\/css\/font-awesome.min.css":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.carousel.css":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.theme.css":1,"sites\/all\/themes\/stability\/vendor\/magnific-popup\/magnific-popup.css":1,"sites\/all\/themes\/stability\/vendor\/mediaelement\/mediaelementplayer.css":1,"sites\/all\/themes\/stability\/css\/theme.css":1,"sites\/all\/themes\/stability\/css\/theme-elements.css":1,"sites\/all\/themes\/stability\/css\/animate.min.css":1,"sites\/all\/themes\/stability\/css\/skins\/red.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/slideshow.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/font-main.css":1,"sites\/all\/themes\/stability\/stability_aspe\/css\/styleless.less":1,"sites\/all\/themes\/stability\/css\/skins\/blue.css":1},"js":{"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.10\/jquery.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/external\/jquery.cookie.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/misc\/jquery.form.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/custom\/aspe\/theme\/js\/aspe.login-confirm.js":1,"sites\/all\/modules\/custom\/aspe_report\/modules\/aspe_databooks\/js\/aspe_databooks.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.highcharts.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.js":1,"sites\/all\/modules\/contrib\/extlink\/extlink.js":1,"sites\/all\/libraries\/datatables\/dataTables.min.js":1,"sites\/all\/libraries\/datatables\/dataTables.responsive.min.js":1,"sites\/all\/libraries\/highcharts\/highcharts.js":1,"sites\/all\/libraries\/highcharts\/highcharts.exporting.js":1,"sites\/all\/libraries\/highcharts\/highcharts.map.js":1,"sites\/all\/libraries\/highcharts\/highcharts.us-all.js":1,"sites\/all\/modules\/custom\/aspe_nodes\/theme\/js\/aspe_nodes.footable.js":1,"http:\/\/s7.addthis.com\/js\/300\/addthis_widget.js#pubid=ra-5486d15a696bff0c":1,"misc\/progress.js":1,"profiles\/openpublic\/modules\/contrib\/webform\/js\/webform.js":1,"profiles\/openpublic\/modules\/contrib\/field_group\/field_group.js":1,"sites\/all\/themes\/stability\/vendor\/jquery-migrate-1.2.1.min.js":1,"sites\/all\/themes\/stability\/vendor\/bootstrap.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.flexnav.min.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.hoverIntent.minified.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.flickrfeed.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.isotope.min.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.isotope.sloppy-masonry.min.js":1,"sites\/all\/themes\/stability\/vendor\/isotope\/jquery.imagesloaded.min.js":1,"sites\/all\/themes\/stability\/vendor\/magnific-popup\/jquery.magnific-popup.js":1,"sites\/all\/themes\/stability\/vendor\/owl-carousel\/owl.carousel.min.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.fitvids.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.appear.js":1,"sites\/all\/themes\/stability\/vendor\/jquery.stellar.min.js":1,"sites\/all\/themes\/stability\/vendor\/snap.svg-min.js":1,"sites\/all\/themes\/stability\/js\/custom.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/aspe.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/html5shiv.min.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/main-menu.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/keyboard-control.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/tabBehavior.js":1,"sites\/all\/themes\/stability\/stability_aspe\/js\/tileStringTrimmer.js":1}},"webform":{"conditionals":{"webform-client-form-158521":{"ruleGroups":[],"sourceMap":[],"values":[]}}},"ajax":{"edit-webform-ajax-next-158521":{"callback":"webform_ajax_callback","wrapper":"webform-ajax-wrapper-158521","progress":{"message":"","type":"throbber"},"event":"click","url":"\/system\/ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Next \u003E"}}},"urlIsAjaxTrusted":{"\/system\/ajax":true,"\/basic-report\/medication-use-medicare-beneficiaries-living-nursing-homes-and-assisted-living-facilities":true},"extlink":{"extTarget":"_blank","extClass":0,"extLabel":"(link is external)","extImgClass":0,"extSubdomains":0,"extExclude":"([a-z0-9]\\.gov)","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":"_blank","extAlertText":"This website contains links to other federal and state agencies and private organizations. The Department of Health and Human Services (HHS) cannot attest to the accuracy of information provided by these nonfederal website links. Linking to nonfederal sites does not constitute an endorsement by HHS or any of its employees of the sponsors or the information and products presented on the sites. You will be subject to the destination site\u0027s privacy policy when you leave the ASPE website.\r\n\r\nThank you for visiting aspe.hhs.gov!","mailtoClass":0,"mailtoLabel":"(link sends e-mail)"},"stability":{"flickr_id":"52617155@N08","logo_sticky":"28"},"field_group":{"div":"full","hidden":"full"}});
//--><!]]>
</script>
  <script type="text/javascript">
<!--//--><![CDATA[//><!--
var addthis_config={pubid:"ra-5486d15a696bff0c",ui_click:false}
//--><!]]>
</script>


  <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"e4837db659","applicationID":"10708002","transactionName":"MwNaZBRSXEtXB0BdWQpJeVMSWl1WGQpbUFM7FllXA2xEUVMT","queueTime":0,"applicationTime":1563,"atts":"H0RZElxIT0U=","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
